{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["automation", "bioinformatics", "computational softwares", "drug design and development", "global health", "innovation", "natural products", "omics", "precision medicine"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29799486", "DateCompleted": {"Year": "2018", "Month": "09", "Day": "26"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "25"}], "Language": ["eng"], "ELocationID": ["1578", "10.3390/ijms19061578"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "19", "Issue": "6", "PubDate": {"Year": "2018", "Month": "May", "Day": "25"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery.", "Abstract": {"AbstractText": ["The therapeutic properties of plants have been recognised since time immemorial. Many pathological conditions have been treated using plant-derived medicines. These medicines are used as concoctions or concentrated plant extracts without isolation of active compounds. Modern medicine however, requires the isolation and purification of one or two active compounds. There are however a lot of global health challenges with diseases such as cancer, degenerative diseases, HIV/AIDS and diabetes, of which modern medicine is struggling to provide cures. Many times the isolation of \"active compound\" has made the compound ineffective. Drug discovery is a multidimensional problem requiring several parameters of both natural and synthetic compounds such as safety, pharmacokinetics and efficacy to be evaluated during drug candidate selection. The advent of latest technologies that enhance drug design hypotheses such as Artificial Intelligence, the use of 'organ-on chip' and microfluidics technologies, means that automation has become part of drug discovery. This has resulted in increased speed in drug discovery and evaluation of the safety, pharmacokinetics and efficacy of candidate compounds whilst allowing novel ways of drug design and synthesis based on natural compounds. Recent advances in analytical and computational techniques have opened new avenues to process complex natural products and to use their structures to derive new and innovative drugs. Indeed, we are in the era of computational molecular design, as applied to natural products. Predictive computational softwares have contributed to the discovery of molecular targets of natural products and their derivatives. In future the use of quantum computing, computational softwares and databases in modelling molecular interactions and predicting features and parameters needed for drug development, such as pharmacokinetic and pharmacodynamics, will result in few false positive leads in drug development. This review discusses plant-based natural product drug discovery and how innovative technologies play a role in next-generation drug discovery."]}, "AuthorList": [{"Identifier": ["0000-0002-3152-5817"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacogenomics and Drug Metabolism Group, Division of Human Genetics, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa. nicholas.thomford@uct.ac.za."}, {"Identifier": [], "Affiliation": "School of Medical Sciences, University of Cape Coast, PMB, Cape Coast, Ghana. nicholas.thomford@uct.ac.za."}], "LastName": "Thomford", "ForeName": "Nicholas Ekow", "Initials": "NE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Wernher and Beit Building (South), University of Cape Town Medical Campus, Anzio Road, Observatory, Cape Town 7925, South Africa. SNTDIM001@myuct.ac.za."}, {"Identifier": [], "Affiliation": "Division of Medical Biochemistry and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa. SNTDIM001@myuct.ac.za."}], "LastName": "Senthebane", "ForeName": "Dimakatso Alice", "Initials": "DA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Wernher and Beit Building (South), University of Cape Town Medical Campus, Anzio Road, Observatory, Cape Town 7925, South Africa. arielle.rowe@icgeb.org."}], "LastName": "Rowe", "ForeName": "Arielle", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacogenomics and Drug Metabolism Group, Division of Human Genetics, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa. MNRDAN002@myuct.ac.za."}], "LastName": "Munro", "ForeName": "Daniella", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Chemical and Systems Biology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa. SLXPAL001@myuct.ac.za."}], "LastName": "Seele", "ForeName": "Palesa", "Initials": "P"}, {"Identifier": ["0000-0001-7965-3415"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, University of Fort Hare, Private Bag, Alice X1314, South Africa. amaroyi@ufh.ac.za."}], "LastName": "Maroyi", "ForeName": "Alfred", "Initials": "A"}, {"Identifier": ["0000-0003-1334-4665"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Wernher and Beit Building (South), University of Cape Town Medical Campus, Anzio Road, Observatory, Cape Town 7925, South Africa. kd.dzobo@uct.ac.za."}, {"Identifier": [], "Affiliation": "Division of Medical Biochemistry and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa. kd.dzobo@uct.ac.za."}], "LastName": "Dzobo", "ForeName": "Kevin", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Artificial Intelligence"}, {"QualifierName": [], "DescriptorName": "Automation, Laboratory"}, {"QualifierName": ["analysis", "chemistry"], "DescriptorName": "Biological Products"}, {"QualifierName": ["methods"], "DescriptorName": "Computational Biology"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Drug Industry"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Models, Chemical"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Robotics"}, {"QualifierName": [], "DescriptorName": "Software"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Weng J.K., Philippe R.N., Noel J.P. The rise of chemodiversity in plants. Science. 2012;336:1667\u20131670. doi: 10.1126/science.1217411.", "ArticleIdList": ["10.1126/science.1217411", "22745420"]}, {"Citation": "Lietava J. Medicinal plants in a Middle Paleolithic grave Shanidar IV? J. Ethnopharmacol. 1992;35:263\u2013266. doi: 10.1016/0378-8741(92)90023-K.", "ArticleIdList": ["10.1016/0378-8741(92)90023-K", "1548898"]}, {"Citation": "Ernst M., Grace O.M., Saslis-Lagoudakis C.H., Nilsson N., Simonsen H.T., Ronsted N. Global medicinal uses of Euphorbia L. (Euphorbiaceae) J. Ethnopharmacol. 2015;176:90\u2013101. doi: 10.1016/j.jep.2015.10.025.", "ArticleIdList": ["10.1016/j.jep.2015.10.025", "26485050"]}, {"Citation": "Gozubuyuk G.S., Aktas E., Yigit N. An ancient plant Lawsonia inermis (henna): Determination of in vitro antifungal activity against dermatophytes species. J. Mycol. Med. 2014;24:313\u2013318. doi: 10.1016/j.mycmed.2014.07.002.", "ArticleIdList": ["10.1016/j.mycmed.2014.07.002", "25442917"]}, {"Citation": "Hotwani K., Baliga S., Sharma K. Phytodentistry: Use of medicinal plants. J. Complement. Integr. Med. 2014;11:233\u2013251. doi: 10.1515/jcim-2013-0015.", "ArticleIdList": ["10.1515/jcim-2013-0015", "25153610"]}, {"Citation": "Liu Q., Lawrence A.J., Liang J.H. Traditional Chinese medicine for treatment of alcoholism: From ancient to modern. Am. J. Chin. Med. 2011;39:1\u201313. doi: 10.1142/S0192415X11008609.", "ArticleIdList": ["10.1142/S0192415X11008609", "21213394"]}, {"Citation": "Mannangatti P., Naidu K.N. Indian herbs for the treatment of neurodegenerative disease. Adv. Neurobiol. 2016;12:323\u2013336.", "ArticleIdList": ["27651261"]}, {"Citation": "McGovern P.E., Mirzoian A., Hall G.R. Ancient Egyptian herbal wines. Proc. Natl. Acad. Sci. USA. 2009;106:7361\u20137366. doi: 10.1073/pnas.0811578106.", "ArticleIdList": ["10.1073/pnas.0811578106", "PMC2678600", "19365069"]}, {"Citation": "Blunt J.W., Carroll A.R., Copp B.R., Davis R.A., Keyzers R.A., Prinsep M.R. Marine natural products. Nat. Prod. Rep. 2018;35:8\u201353. doi: 10.1039/C7NP00052A.", "ArticleIdList": ["10.1039/C7NP00052A", "29335692"]}, {"Citation": "Harvey A.L. Natural products in drug discovery. Drug Discov. Today. 2008;13:894\u2013901. doi: 10.1016/j.drudis.2008.07.004.", "ArticleIdList": ["10.1016/j.drudis.2008.07.004", "18691670"]}, {"Citation": "Harvey A.L., Clark R.L., Mackay S.P., Johnston B.F. Current strategies for drug discovery through natural products. Expert Opin. Drug Discov. 2010;5:559\u2013568. doi: 10.1517/17460441.2010.488263.", "ArticleIdList": ["10.1517/17460441.2010.488263", "22823167"]}, {"Citation": "Harvey A.L., Edrada-Ebel R., Quinn R.J. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 2015;14:111\u2013129. doi: 10.1038/nrd4510.", "ArticleIdList": ["10.1038/nrd4510", "25614221"]}, {"Citation": "Chang J., Kim Y., Kwon H.J. Advances in identification and validation of protein targets of natural products without chemical modification. Nat. Prod. Rep. 2016;33:719\u2013730. doi: 10.1039/C5NP00107B.", "ArticleIdList": ["10.1039/C5NP00107B", "26964663"]}, {"Citation": "Tansaz M., Tajadini H. Comparison of leiomyoma of modern medicine and traditional Persian medicine. J. Evid.-Based Complement. Altern. Med. 2016;21:160\u2013163. doi: 10.1177/2156587215595299.", "ArticleIdList": ["10.1177/2156587215595299", "26177818"]}, {"Citation": "Xu Q., Bauer R., Hendry B.M., Fan T.P., Zhao Z., Duez P., Simmonds M.S., Witt C.M., Lu A., Robinson N., et al. The quest for modernisation of traditional Chinese medicine. BMC Complement. Altern. Med. 2013;13:132. doi: 10.1186/1472-6882-13-132.", "ArticleIdList": ["10.1186/1472-6882-13-132", "PMC3689083", "23763836"]}, {"Citation": "Yuan H., Ma Q., Ye L., Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21:559. doi: 10.3390/molecules21050559.", "ArticleIdList": ["10.3390/molecules21050559", "PMC6273146", "27136524"]}, {"Citation": "Banjari I., Misir A., Savikin K., Jokic S., Molnar M., De Zoysa H.K.S., Waisundara V.Y. Antidiabetic effects of Aronia melanocarpa and its other therapeutic properties. Front. Nutr. 2017;4:53. doi: 10.3389/fnut.2017.00053.", "ArticleIdList": ["10.3389/fnut.2017.00053", "PMC5681526", "29164127"]}, {"Citation": "Yatoo M.I., Dimri U., Gopalakrishnan A., Karthik K., Gopi M., Khandia R., Saminathan M., Saxena A., Alagawany M., Farag M.R., et al. Beneficial health applications and medicinal values of pedicularis plants: A review. Biomed. Pharmacother. 2017;95:1301\u20131313. doi: 10.1016/j.biopha.2017.09.041.", "ArticleIdList": ["10.1016/j.biopha.2017.09.041", "28938521"]}, {"Citation": "Thomford N.E., Awortwe C., Dzobo K., Adu F., Chopera D., Wonkam A., Skelton M., Blackhurst D., Dandara C. Inhibition of cyp2b6 by medicinal plant extracts: Implication for use of efavirenz and nevirapine-based highly active anti-retroviral therapy (HAART) in resource-limited settings. Molecules. 2016;21:211. doi: 10.3390/molecules21020211.", "ArticleIdList": ["10.3390/molecules21020211", "PMC6273559", "26891286"]}, {"Citation": "Thomford N.E., Dzobo K., Chopera D., Wonkam A., Maroyi A., Blackhurst D., Dandara C. In vitro reversible and time-dependent cyp450 inhibition profiles of medicinal herbal plant extracts Newbouldia laevis and Cassia abbreviata: Implications for herb-drug interactions. Molecules. 2016;21:891. doi: 10.3390/molecules21070891.", "ArticleIdList": ["10.3390/molecules21070891", "PMC6274561", "27399660"]}, {"Citation": "Thomford N.E., Dzobo K., Chopera D., Wonkam A., Skelton M., Blackhurst D., Chirikure S., Dandara C. Pharmacogenomics implications of using herbal medicinal plants on African populations in health transition. Pharmaceuticals. 2015;8:637\u2013663. doi: 10.3390/ph8030637.", "ArticleIdList": ["10.3390/ph8030637", "PMC4588186", "26402689"]}, {"Citation": "Thomford N.E., Mkhize B., Dzobo K., Mpye K., Rowe A., Parker M.I., Wonkam A., Skelton M., September A.V., Dandara C. African lettuce (Launaea taraxacifolia) displays possible anticancer effects and herb-drug interaction potential by CYP1A2, CYP2C9, and CYP2C19 inhibition. Omics. 2016;20:528\u2013537. doi: 10.1089/omi.2016.0117.", "ArticleIdList": ["10.1089/omi.2016.0117", "27631192"]}, {"Citation": "Ji S., Fattahi A., Raffel N., Hoffmann I., Beckmann M.W., Dittrich R., Schrauder M. Antioxidant effect of aqueous extract of four plants with therapeutic potential on gynecological diseases; semen persicae, Leonurus cardiaca, Hedyotis diffusa, and Curcuma zedoaria. Eur. J. Med. Res. 2017;22:50. doi: 10.1186/s40001-017-0293-6.", "ArticleIdList": ["10.1186/s40001-017-0293-6", "PMC5702154", "29178942"]}, {"Citation": "Ruhsam M., Hollingsworth P.M. Authentication of eleutherococcus and rhodiola herbal supplement products in the United Kingdom. J. Pharm. Biomed. Anal. 2017;149:403\u2013409. doi: 10.1016/j.jpba.2017.11.025.", "ArticleIdList": ["10.1016/j.jpba.2017.11.025", "29154110"]}, {"Citation": "Patridge E., Gareiss P., Kinch M.S., Hoyer D. An analysis of FDA-approved drugs: Natural products and their derivatives. Drug Discov. Today. 2016;21:204\u2013207. doi: 10.1016/j.drudis.2015.01.009.", "ArticleIdList": ["10.1016/j.drudis.2015.01.009", "25617672"]}, {"Citation": "Wani M.C., Taylor H.L., Wall M.E., Coggon P., McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 1971;93:2325\u20132327. doi: 10.1021/ja00738a045.", "ArticleIdList": ["10.1021/ja00738a045", "5553076"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012;75:311\u2013335. doi: 10.1021/np200906s.", "ArticleIdList": ["10.1021/np200906s", "PMC3721181", "22316239"]}, {"Citation": "Carter G.T. Natural products and Pharma 2011: Strategic changes spur new opportunities. Nat. Prod. Rep. 2011;28:1783\u20131789. doi: 10.1039/c1np00033k.", "ArticleIdList": ["10.1039/c1np00033k", "21909580"]}, {"Citation": "Li J.W., Vederas J.C. Drug discovery and natural products: End of an era or an endless frontier? Science. 2009;325:161\u2013165. doi: 10.1126/science.1168243.", "ArticleIdList": ["10.1126/science.1168243", "19589993"]}, {"Citation": "Li F.S., Weng J.K. Demystifying traditional herbal medicine with modern approach. Nat. Plants. 2017;3:17109. doi: 10.1038/nplants.2017.109.", "ArticleIdList": ["10.1038/nplants.2017.109", "28758992"]}, {"Citation": "Kiyohara H., Matsumoto T., Yamada H. Combination effects of herbs in a multi-herbal formula: Expression of juzen-taiho-to\u2019s immuno-modulatory activity on the intestinal immune system. Evid.-Based Complement. Altern. Med. 2004;1:83\u201391. doi: 10.1093/ecam/neh004.", "ArticleIdList": ["10.1093/ecam/neh004", "PMC526207", "15257329"]}, {"Citation": "Leonti M., Verpoorte R. Traditional Mediterranean and European herbal medicines. J. Ethnopharmacol. 2017;199:161\u2013167. doi: 10.1016/j.jep.2017.01.052.", "ArticleIdList": ["10.1016/j.jep.2017.01.052", "28179113"]}, {"Citation": "Ozdemir V., Hekim N. Birth of industry 5.0: Making sense of big data with artificial intelligence, \u201cthe internet of things\u201d and next-generation technology policy. Omics. 2018;22:65\u201376. doi: 10.1089/omi.2017.0194.", "ArticleIdList": ["10.1089/omi.2017.0194", "29293405"]}, {"Citation": "\u00d6zdemir V. Omics 2.0: An accelerator for global science, systems medicine and responsible innovation. Omics. 2015;19:579\u2013580. doi: 10.1089/omi.2015.0133.", "ArticleIdList": ["10.1089/omi.2015.0133", "PMC4615774", "26484977"]}, {"Citation": "Wall M.E., Wani M.C., Brown D.M., Fullas F., Olwald J.B., Josephson F.F., Thornton N.M., Pezzuto J.M., Beecher C.W., Farnsworth N.R., et al. Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal. Phytomedicine. 1996;3:281\u2013285. doi: 10.1016/S0944-7113(96)80067-5.", "ArticleIdList": ["10.1016/S0944-7113(96)80067-5", "23195084"]}, {"Citation": "Eldridge G.R., Vervoort H.C., Lee C.M., Cremin P.A., Williams C.T., Hart S.M., Goering M.G., O\u2019Neil-Johnson M., Zeng L. High-throughput method for the production and analysis of large natural product libraries for drug discovery. Anal. Chem. 2002;74:3963\u20133971. doi: 10.1021/ac025534s.", "ArticleIdList": ["10.1021/ac025534s", "12199561"]}, {"Citation": "Wu S., Liang J. Counter-current chromatography for high throughput analysis of natural products. Comb. Chem. High Throughput Screen. 2010;13:932\u2013942. doi: 10.2174/138620710793360248.", "ArticleIdList": ["10.2174/138620710793360248", "20883188"]}, {"Citation": "Bugni T.S., Richards B., Bhoite L., Cimbora D., Harper M.K., Ireland C.M. Marine natural product libraries for high-throughput screening and rapid drug discovery. J. Nat. Prod. 2008;71:1095\u20131098. doi: 10.1021/np800184g.", "ArticleIdList": ["10.1021/np800184g", "PMC2533854", "18505284"]}, {"Citation": "Koehn F.E. Natural Compounds as Drugs Volume I. Volume 65. Birkh\u00e4user; Basel, Switzerland: 2008. High impact technologies for natural products screening; pp. 175\u2013210.", "ArticleIdList": ["18084916"]}, {"Citation": "Wong W.R., Oliver A.G., Linington R.G. Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics. Chem. Biol. 2012;19:1483\u20131495. doi: 10.1016/j.chembiol.2012.09.014.", "ArticleIdList": ["10.1016/j.chembiol.2012.09.014", "PMC7505084", "23177202"]}, {"Citation": "He G., Yin Y., Yan X., Wang Y. Semi-bionic extraction of effective ingredient from fishbone by high intensity pulsed electric fields. J. Food Process Eng. 2017;40:e12392. doi: 10.1111/jfpe.12392.", "ArticleIdList": ["10.1111/jfpe.12392"]}, {"Citation": "Yoshioka T., Nagatomi Y., Harayama K., Bamba T. Development of an analytical method for polycyclic aromatic hydrocarbons in coffee beverages and dark beer using novel high-sensitivity technique of supercritical fluid chromatography/mass spectrometry. J. Biosci. Bioeng. 2018 doi: 10.1016/j.jbiosc.2018.01.014.", "ArticleIdList": ["10.1016/j.jbiosc.2018.01.014", "29499993"]}, {"Citation": "Hofstetter R., Fassauer G.M., Link A. Supercritical fluid extraction (SFE) of ketamine metabolites from dried urine and on-line quantification by supercritical fluid chromatography and single mass detection (on-line SFE\u2013SFC\u2013MS) J. Chromatogr. B. 2018;1076:77\u201383. doi: 10.1016/j.jchromb.2018.01.024.", "ArticleIdList": ["10.1016/j.jchromb.2018.01.024", "29406031"]}, {"Citation": "Morales D., Piris A.J., Ruiz-Rodriguez A., Prodanov M., Soler-Rivas C. Extraction of bioactive compounds against cardiovascular diseases from Lentinula edodes using a sequential extraction method. Biotechnol. Prog. 2018 doi: 10.1002/btpr.2616.", "ArticleIdList": ["10.1002/btpr.2616", "29388355"]}, {"Citation": "Joana Gil-Ch\u00e1vez G., Villa J.A., Fernando Ayala-Zavala J., Basilio Heredia J., Sepulveda D., Yahia E.M., Gonz\u00e1lez-Aguilar G.A. Technologies for extraction and production of bioactive compounds to be used as nutraceuticals and food ingredients: An overview. Compr. Rev. Food Sci. Food Saf. 2013;12:5\u201323. doi: 10.1111/1541-4337.12005.", "ArticleIdList": ["10.1111/1541-4337.12005"]}, {"Citation": "De Morais S.R., Oliveira T.L., de Oliveira L.P., Tresvenzol L.M., da Conceicao E.C., Rezende M.H., Fiuza T.S., Costa E.A., Ferri P.H., de Paula J.R. Essential oil composition, antimicrobial and pharmacological activities of Lippia sidoides cham. (verbenaceae) from Sao Goncalo do Abaete, Minas Gerais, Brazil. Pharmacogn. Mag. 2016;12:262\u2013270.", "ArticleIdList": ["PMC5096271", "27867267"]}, {"Citation": "Gan Z., Liang Z., Chen X., Wen X., Wang Y., Li M., Ni Y. Separation and preparation of 6-gingerol from molecular distillation residue of Yunnan ginger rhizomes by high-speed counter-current chromatography and the antioxidant activity of ginger oils in vitro. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2016;1011:99\u2013107. doi: 10.1016/j.jchromb.2015.12.051.", "ArticleIdList": ["10.1016/j.jchromb.2015.12.051", "26773887"]}, {"Citation": "Zhang L., Mei J., Xie Y., Li M., Liu D., He C. Application of membrane separation technology in extraction process of Chuanxiong Chatiao granules. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J. Chin. Mater. Med. 2012;37:934\u2013936.", "ArticleIdList": ["22792792"]}, {"Citation": "Williams S., Oatley D., Abdrahman A., Butt T., Nash R. Membrane technology for the improved separation of bioactive compounds. Procedia Eng. 2012;44:2112\u20132114. doi: 10.1016/j.proeng.2012.09.064.", "ArticleIdList": ["10.1016/j.proeng.2012.09.064"]}, {"Citation": "Wang H., Jiang Y., Ding M., Li J., Hao J., He J., Wang H., Gao X.M., Chang Y.X. Simultaneous determination and qualitative analysis of six types of components in Naoxintong capsule by miniaturized matrix solid-phase dispersion extraction coupled with ultra high-performance liquid chromatography with photodiode array detection and quadrupole time-of-flight mass spectrometry. J. Sep. Sci. 2018 doi: 10.1002/jssc.201701411.", "ArticleIdList": ["10.1002/jssc.201701411", "29396922"]}, {"Citation": "Zhang L., Ge Y., Li J., Hao J., Wang H., He J., Gao X.M., Chang Y.X. Simultaneous determination of columbianetin-beta-d-glucopyranoside and columbianetin in a biological sample by high-performance liquid chromatography with fluorescence detection and identification of other columbianetin-beta-d-glucopyranoside metabolites by ultra high-performance liquid chromatography coupled with quadrupole-time of flight mass spectrometry. J. Pharm. Biomed. Anal. 2018;153:221\u2013231.", "ArticleIdList": ["29506005"]}, {"Citation": "Manglik A., Kruse A.C., Kobilka T.S., Thian F.S., Mathiesen J.M., Sunahara R.K., Pardo L., Weis W.I., Kobilka B.K., Granier S. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature. 2012;485:321\u2013326. doi: 10.1038/nature10954.", "ArticleIdList": ["10.1038/nature10954", "PMC3523197", "22437502"]}, {"Citation": "Edwards G. Forces of habit: Drugs and the making of the modern world. Addiction. 2002;97:608\u2013609. doi: 10.1046/j.1360-0443.2002.t01-9-00166.x.", "ArticleIdList": ["10.1046/j.1360-0443.2002.t01-9-00166.x"]}, {"Citation": "Zhao L., Li C., Zhang Y., Wen Q., Ren D. Phytochemical and biological activities of an anticancer plant medicine: Brucea javanica. Anti-Cancer Agents Med. Chem. 2014;14:440\u2013458. doi: 10.2174/18715206113136660336.", "ArticleIdList": ["10.2174/18715206113136660336", "24066797"]}, {"Citation": "Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat. Med. 2011;17:1217\u20131220. doi: 10.1038/nm.2471.", "ArticleIdList": ["10.1038/nm.2471", "21989013"]}, {"Citation": "Tu Y. Artemisinin\u2014A gift from traditional Chinese medicine to the world (Nobel lecture) Angew. Chem. Int. Ed. Engl. 2016;55:10210\u201310226. doi: 10.1002/anie.201601967.", "ArticleIdList": ["10.1002/anie.201601967", "27488942"]}, {"Citation": "Li J., Casteels T., Frogne T., Ingvorsen C., Honor\u00e9 C., Courtney M., Huber K.V.M., Schmitner N., Kimmel R.A., Romanov R.A., et al. Artemisinins target GABAA receptor signaling and impair \u03b1 cell identity. Cell. 2017;168:86\u2013100. doi: 10.1016/j.cell.2016.11.010.", "ArticleIdList": ["10.1016/j.cell.2016.11.010", "PMC5236063", "27916275"]}, {"Citation": "Lai H., Singh N.P. Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (dmba)-induced breast cancer in the rat. Cancer Lett. 2006;231:43\u201348. doi: 10.1016/j.canlet.2005.01.019.", "ArticleIdList": ["10.1016/j.canlet.2005.01.019", "16356830"]}, {"Citation": "Lai H.C., Singh N.P., Sasaki T. Development of artemisinin compounds for cancer treatment. Investig. New Drugs. 2013;31:230\u2013246. doi: 10.1007/s10637-012-9873-z.", "ArticleIdList": ["10.1007/s10637-012-9873-z", "22935909"]}, {"Citation": "Return to Rio: Second chance for the planet. Nature. 2012;486:19.", "ArticleIdList": ["22678261"]}, {"Citation": "Barbault R. 2010: A new beginning for biodiversity? C.R. Biol. 2011;334:483\u2013488. doi: 10.1016/j.crvi.2011.02.002.", "ArticleIdList": ["10.1016/j.crvi.2011.02.002", "21640957"]}, {"Citation": "Salazar R., Cabrera J.A. Intellectual property rights in Costa Rica in the light of the biodiversity convention. J. Ethnopharmacol. 1996;51:177\u2013193. doi: 10.1016/0378-8741(95)01360-1.", "ArticleIdList": ["10.1016/0378-8741(95)01360-1", "9213615"]}, {"Citation": "Samper C. Taxonomy and environmental policy. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2004;359:721\u2013728. doi: 10.1098/rstb.2004.1476.", "ArticleIdList": ["10.1098/rstb.2004.1476", "PMC1693350", "15253357"]}, {"Citation": "Seidl P.R. Pharmaceuticals from natural products: Current trends. Anais da Academia Brasileira de Ciencias. 2002;74:145\u2013150. doi: 10.1590/S0001-37652002000100011.", "ArticleIdList": ["10.1590/S0001-37652002000100011", "11960183"]}, {"Citation": "Tollefson J., Gilbert N. Earth summit: Rio report card. Nature. 2012;486:20\u201323. doi: 10.1038/486020a.", "ArticleIdList": ["10.1038/486020a", "22678262"]}, {"Citation": "Wen M.C., Wei C.H., Hu Z.Q., Srivastava K., Ko J., Xi S.T., Mu D.Z., Du J.B., Li G.H., Wallenstein S., et al. Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J. Allergy Clin. Immunol. 2005;116:517\u2013524. doi: 10.1016/j.jaci.2005.05.029.", "ArticleIdList": ["10.1016/j.jaci.2005.05.029", "16159618"]}, {"Citation": "Srivastava K., Sampson H.A., Charles W., Emala S., Li X.-M. The anti-asthma herbal medicine ashmi acutely inhibits airway smooth muscle contraction via prostaglandin e2 activation of ep2/ep4 receptors. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2013;305:L1002\u2013L1010. doi: 10.1152/ajplung.00423.2012.", "ArticleIdList": ["10.1152/ajplung.00423.2012", "PMC3882537", "24163140"]}, {"Citation": "Yang N., Liang B., Srivastava K., Zeng J., Zhan J., Brown L., Sampson H., Goldfarb J., Emala C., Li X.M. The Sophora flavescens flavonoid compound trifolirhizin inhibits acetylcholine induced airway smooth muscle contraction. Phytochemistry. 2013;95:259\u2013267. doi: 10.1016/j.phytochem.2013.07.023.", "ArticleIdList": ["10.1016/j.phytochem.2013.07.023", "PMC4118489", "23993294"]}, {"Citation": "Chan K., Shaw D., Simmonds M.S., Leon C.J., Xu Q., Lu A., Sutherland I., Ignatova S., Zhu Y.P., Verpoorte R., et al. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. J. Ethnopharmacol. 2012;140:469\u2013475. doi: 10.1016/j.jep.2012.01.038.", "ArticleIdList": ["10.1016/j.jep.2012.01.038", "22330011"]}, {"Citation": "Skroza D., Generali\u0107 Mekini\u0107 I., Svilovi\u0107 S., \u0160imat V., Katalini\u0107 V. Investigation of the potential synergistic effect of resveratrol with other phenolic compounds: A case of binary phenolic mixtures. J. Food Compos. Anal. 2015;38:13\u201318. doi: 10.1016/j.jfca.2014.06.013.", "ArticleIdList": ["10.1016/j.jfca.2014.06.013"]}, {"Citation": "Chusri S., Siriyong T., Na-Phatthalung P., Voravuthikunchai S.P. Synergistic effects of ethnomedicinal plants of Apocynaceae family and antibiotics against clinical isolates of Acinetobacter baumannii. Asian Pac. J. Trop. Med. 2014;7:456\u2013461. doi: 10.1016/S1995-7645(14)60074-2.", "ArticleIdList": ["10.1016/S1995-7645(14)60074-2", "25066394"]}, {"Citation": "Sharma G., Tyagi A.K., Singh R.P., Chan D.C., Agarwal R. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells. Breast Cancer Res. Treat. 2004;85:1\u201312. doi: 10.1023/B:BREA.0000020991.55659.59.", "ArticleIdList": ["10.1023/B:BREA.0000020991.55659.59", "15039593"]}, {"Citation": "Medema M.H., Fischbach M.A. Computational approaches to natural product discovery. Nat. Chem. Biol. 2015;11:639\u2013648. doi: 10.1038/nchembio.1884.", "ArticleIdList": ["10.1038/nchembio.1884", "PMC5024737", "26284671"]}, {"Citation": "Kim E., Moore B.S., Yoon Y.J. Reinvigorating natural product combinatorial biosynthesis with synthetic biology. Nat. Chem. Biol. 2015;11:649\u2013659. doi: 10.1038/nchembio.1893.", "ArticleIdList": ["10.1038/nchembio.1893", "PMC4757526", "26284672"]}, {"Citation": "Akbulut Y., Gaunt H.J., Muraki K., Ludlow M.J., Amer M.S., Bruns A., Vasudev N.S., Radtke L., Willot M., Hahn S., et al. (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels. Angew. Chem. Int. Ed. Engl. 2015;54:3787\u20133791. doi: 10.1002/anie.201411511.", "ArticleIdList": ["10.1002/anie.201411511", "PMC7116557", "25707820"]}, {"Citation": "Ludlow M.J., Gaunt H.J., Rubaiy H.N., Musialowski K.E., Blythe N.M., Vasudev N.S., Muraki K., Beech D.J. (-)-Englerin A-evoked cytotoxicity is mediated by Na+ influx and counteracted by Na+/K+-atpase. J. Biol. Chem. 2017;292:723\u2013731. doi: 10.1074/jbc.M116.755678.", "ArticleIdList": ["10.1074/jbc.M116.755678", "PMC5241745", "27875305"]}, {"Citation": "Muraki K., Ohnishi K., Takezawa A., Suzuki H., Hatano N., Muraki Y., Hamzah N., Foster R., Waldmann H., Nussbaumer P., et al. Na(+) entry through heteromeric TRPC4/C1 channels mediates (-)Englerin A-induced cytotoxicity in synovial sarcoma cells. Sci. Rep. 2017;7:16988. doi: 10.1038/s41598-017-17303-3.", "ArticleIdList": ["10.1038/s41598-017-17303-3", "PMC5717101", "29209034"]}, {"Citation": "Buriani A., Garcia-Bermejo M.L., Bosisio E., Xu Q., Li H., Dong X., Simmonds M.S., Carrara M., Tejedor N., Lucio-Cazana J., et al. Omic techniques in systems biology approaches to traditional Chinese medicine research: Present and future. J. Ethnopharmacol. 2012;140:535\u2013544. doi: 10.1016/j.jep.2012.01.055.", "ArticleIdList": ["10.1016/j.jep.2012.01.055", "22342380"]}, {"Citation": "Ganie S.H., Upadhyay P., Das S., Prasad Sharma M. Authentication of medicinal plants by DNA markers. Plant Gene. 2015;4:83\u201399. doi: 10.1016/j.plgene.2015.10.002.", "ArticleIdList": ["10.1016/j.plgene.2015.10.002", "PMC7103949", "32289060"]}, {"Citation": "Ghorbani A., Saeedi Y., de Boer H.J. Unidentifiable by morphology: DNA barcoding of plant material in local markets in Iran. PLoS ONE. 2017;12:e0175722. doi: 10.1371/journal.pone.0175722.", "ArticleIdList": ["10.1371/journal.pone.0175722", "PMC5395179", "28419161"]}, {"Citation": "Thompson K.A., Newmaster S.G. Molecular taxonomic tools provide more accurate estimates of species richness at less cost than traditional morphology-based taxonomic practices in a vegetation survey. Biodivers. Conserv. 2014;23:1411\u20131424. doi: 10.1007/s10531-014-0672-z.", "ArticleIdList": ["10.1007/s10531-014-0672-z"]}, {"Citation": "Cao M., Wang J., Yao L., Xie S., Du J., Zhao X. Authentication of animal signatures in traditional Chinese medicine of Lingyang Qingfei Wan using routine molecular diagnostic assays. Mol. Biol. Rep. 2014;41:2485\u20132491. doi: 10.1007/s11033-014-3105-x.", "ArticleIdList": ["10.1007/s11033-014-3105-x", "24445529"]}, {"Citation": "Newmaster S.G., Grguric M., Shanmughanandhan D., Ramalingam S., Ragupathy S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med. 2013;11:222. doi: 10.1186/1741-7015-11-222.", "ArticleIdList": ["10.1186/1741-7015-11-222", "PMC3851815", "24120035"]}, {"Citation": "Mishra P., Kumar A., Nagireddy A., Mani D.N., Shukla A.K., Tiwari R., Sundaresan V. DNA barcoding: An efficient tool to overcome authentication challenges in the herbal market. Plant Biotechnol. J. 2016;14:8\u201321. doi: 10.1111/pbi.12419.", "ArticleIdList": ["10.1111/pbi.12419", "26079154"]}, {"Citation": "Chen X., Xiang L., Shi L., Li G., Yao H., Han J., Lin Y., Song J., Chen S. Identification of crude drugs in the Japanese pharmacopoeia using a DNA barcoding system. Sci. Rep. 2017;7:42325. doi: 10.1038/srep42325.", "ArticleIdList": ["10.1038/srep42325", "PMC5301229", "28186159"]}, {"Citation": "Pulice G., Pelaz S., Mat\u00edas-Hern\u00e1ndez L. Molecular farming in Artemisia annua, a promising approach to improve anti-malarial drug production. Front. Plant Sci. 2016;7:329. doi: 10.3389/fpls.2016.00329.", "ArticleIdList": ["10.3389/fpls.2016.00329", "PMC4796020", "27047510"]}, {"Citation": "Gantait S., Debnath S., Nasim Ali M. Genomic profile of the plants with pharmaceutical value. 3 Biotech. 2014;4:563\u2013578. doi: 10.1007/s13205-014-0218-9.", "ArticleIdList": ["10.1007/s13205-014-0218-9", "PMC4235889", "28324311"]}, {"Citation": "Lv C., Wu X., Wang X., Su J., Zeng H., Zhao J., Lin S., Liu R., Li H., Li X., et al. The gene expression profiles in response to 102 traditional Chinese medicine (TCM) components: A general template for research on TCMs. Sci. Rep. 2017;7:352. doi: 10.1038/s41598-017-00535-8.", "ArticleIdList": ["10.1038/s41598-017-00535-8", "PMC5428649", "28336967"]}, {"Citation": "Lee K.-H., Lo H.-L., Tang W.-C., Hsiao H.H.-Y., Yang P.-M. A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine Berberine. Sci. Rep. 2014;4:6394. doi: 10.1038/srep06394.", "ArticleIdList": ["10.1038/srep06394", "PMC5377252", "25227736"]}, {"Citation": "Kiyama R. DNA microarray-based screening and characterization of traditional Chinese medicine. Microarrays. 2017;6:4. doi: 10.3390/microarrays6010004.", "ArticleIdList": ["10.3390/microarrays6010004", "PMC5374364", "28146102"]}, {"Citation": "Jones M.J., Goodman S.J., Kobor M.S. DNA methylation and healthy human aging. Aging Cell. 2015;14:924\u2013932. doi: 10.1111/acel.12349.", "ArticleIdList": ["10.1111/acel.12349", "PMC4693469", "25913071"]}, {"Citation": "Kelly T.K., Liu Y., Lay F.D., Liang G., Berman B.P., Jones P.A. Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules. Genome Res. 2012;22:2497\u20132506. doi: 10.1101/gr.143008.112.", "ArticleIdList": ["10.1101/gr.143008.112", "PMC3514679", "22960375"]}, {"Citation": "Nordlund J., Backlin C.L., Wahlberg P., Busche S., Berglund E.C., Eloranta M.L., Flaegstad T., Forestier E., Frost B.M., Harila-Saari A., et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 2013;14:r105. doi: 10.1186/gb-2013-14-9-r105.", "ArticleIdList": ["10.1186/gb-2013-14-9-r105", "PMC4014804", "24063430"]}, {"Citation": "Su J., Wang Y., Xing X., Liu J., Zhang Y. Genome-wide analysis of DNA methylation in bovine placentas. BMC Genom. 2014;15:12. doi: 10.1186/1471-2164-15-12.", "ArticleIdList": ["10.1186/1471-2164-15-12", "PMC3893433", "24397284"]}, {"Citation": "Zykovich A., Hubbard A., Flynn J.M., Tarnopolsky M., Fraga M.F., Kerksick C., Ogborn D., MacNeil L., Mooney S.D., Melov S. Genome-wide DNA methylation changes with age in disease-free human skeletal muscle. Aging Cell. 2014;13:360\u2013366. doi: 10.1111/acel.12180.", "ArticleIdList": ["10.1111/acel.12180", "PMC3954952", "24304487"]}, {"Citation": "Barbosa S., Carreira S., Bailey D., Abaitua F., O\u2019Hare P. Phosphorylation and SCF-mediated degradation regulate CREB-H transcription of metabolic targets. Mol. Biol. Cell. 2015;26:2939\u20132954. doi: 10.1091/mbc.e15-04-0247.", "ArticleIdList": ["10.1091/mbc.e15-04-0247", "PMC4571331", "26108621"]}, {"Citation": "Bose P., Vachhani P., Cortes J.E. Treatment of relapsed/refractory acute myeloid leukemia. Curr. Treat. Options Oncol. 2017;18:17. doi: 10.1007/s11864-017-0456-2.", "ArticleIdList": ["10.1007/s11864-017-0456-2", "28286924"]}, {"Citation": "Ley T.J., Miller C., Ding L., Raphael B.J., Mungall A.J., Robertson A., Hoadley K., Triche T.J., Jr., Laird P.W., Baty J.D., et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 2013;368:2059\u20132074.", "ArticleIdList": ["PMC3767041", "23634996"]}, {"Citation": "Brat D.J., Verhaak R.G., Aldape K.D., Yung W.K., Salama S.R., Cooper L.A., Rheinbay E., Miller C.R., Vitucci M., Morozova O., et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 2015;372:2481\u20132498.", "ArticleIdList": ["PMC4530011", "26061751"]}, {"Citation": "Eckel-Passow J.E., Lachance D.H., Molinaro A.M., Walsh K.M., Decker P.A., Sicotte H., Pekmezci M., Rice T., Kosel M.L., Smirnov I.V., et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N. Engl. J. Med. 2015;372:2499\u20132508. doi: 10.1056/NEJMoa1407279.", "ArticleIdList": ["10.1056/NEJMoa1407279", "PMC4489704", "26061753"]}, {"Citation": "Mwapagha L.M., Tiffin N., Parker M.I. Delineation of the HPV11e6 and HPV18e6 pathways in initiating cellular transformation. Front. Oncol. 2017;7:258. doi: 10.3389/fonc.2017.00258.", "ArticleIdList": ["10.3389/fonc.2017.00258", "PMC5672010", "29164058"]}, {"Citation": "Vogelsang M., Wang Y., Veber N., Mwapagha L.M., Parker M.I. The cumulative effects of polymorphisms in the DNA mismatch repair genes and tobacco smoking in oesophageal cancer risk. PLoS ONE. 2012;7:e36962. doi: 10.1371/journal.pone.0036962.", "ArticleIdList": ["10.1371/journal.pone.0036962", "PMC3356375", "22623965"]}, {"Citation": "Fishilevich S., Nudel R., Rappaport N., Hadar R., Plaschkes I., Iny Stein T., Rosen N., Kohn A., Twik M., Safran M., et al. Genehancer: Genome-wide integration of enhancers and target genes in genecards. Database. 2017;2017 doi: 10.1093/database/bax028.", "ArticleIdList": ["10.1093/database/bax028", "PMC5467550", "28605766"]}, {"Citation": "Guo X., Long J., Zeng C., Michailidou K., Ghoussaini M., Bolla M.K., Wang Q., Milne R.L., Shu X.O., Cai Q., et al. Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk. Cancer Epidemiol. Biomark. Prev. 2015;24:1680\u20131691. doi: 10.1158/1055-9965.EPI-15-0363.", "ArticleIdList": ["10.1158/1055-9965.EPI-15-0363", "PMC4633342", "26354892"]}, {"Citation": "Ombrello M.J., Sikora K.A., Kastner D.L. Genetics, genomics, and their relevance to pathology and therapy. Best Pract. Res. Clin. Rheumatol. 2014;28:175\u2013189. doi: 10.1016/j.berh.2014.05.001.", "ArticleIdList": ["10.1016/j.berh.2014.05.001", "PMC4149217", "24974057"]}, {"Citation": "Simmonds P., Loomis E., Curry E. DNA methylation-based chromatin compartments and CHIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis. Genome Med. 2017;9:54. doi: 10.1186/s13073-017-0443-z.", "ArticleIdList": ["10.1186/s13073-017-0443-z", "PMC5463361", "28592290"]}, {"Citation": "Yang T.Y., Hsu L.I., Chiu A.W., Pu Y.S., Wang S.H., Liao Y.T., Wu M.M., Wang Y.H., Chang C.H., Lee T.C., et al. Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure. Environ. Res. 2014;128:57\u201363. doi: 10.1016/j.envres.2013.10.006.", "ArticleIdList": ["10.1016/j.envres.2013.10.006", "24268366"]}, {"Citation": "Mehta G., Jalan R., Mookerjee R.P. Cracking the encode: From transcription to therapeutics. Hepatology. 2013;57:2532\u20132535. doi: 10.1002/hep.26449.", "ArticleIdList": ["10.1002/hep.26449", "23609523"]}, {"Citation": "Tragante V., Moore J.H., Asselbergs F.W. The encode project and perspectives on pathways. Genet. Epidemiol. 2014;38:275\u2013280. doi: 10.1002/gepi.21802.", "ArticleIdList": ["10.1002/gepi.21802", "24723339"]}, {"Citation": "Bumpus S.B., Evans B.S., Thomas P.M., Ntai I., Kelleher N.L. A proteomics approach to discovery of natural products and their biosynthetic pathways. Nat. Biotechnol. 2009;27:951\u2013956. doi: 10.1038/nbt.1565.", "ArticleIdList": ["10.1038/nbt.1565", "PMC2782881", "19767731"]}, {"Citation": "Mart\u00ednez-Esteso M.J., Mart\u00ednez-M\u00e1rquez A., Sell\u00e9s-Marchart S., Morante-Carriel J.A., Bru-Mart\u00ednez R. The role of proteomics in progressing insights into plant secondary metabolism. Front. Plant Sci. 2015;6:504. doi: 10.3389/fpls.2015.00504.", "ArticleIdList": ["10.3389/fpls.2015.00504", "PMC4493368", "26217358"]}, {"Citation": "Lum J.H., Fung K.L., Cheung P.Y., Wong M.S., Lee C.H., Kwok F.S., Leung M.C., Hui P.K., Lo S.C. Proteome of oriental ginseng Panax ginseng C.A. Meyer and the potential to use it as an identification tool. Proteomics. 2002;2:1123\u20131130. doi: 10.1002/1615-9861(200209)2:9<1123::AID-PROT1123>3.0.CO;2-S.", "ArticleIdList": ["10.1002/1615-9861(200209)2:9<1123::AID-PROT1123>3.0.CO;2-S", "12362331"]}, {"Citation": "Kim S.W., Lee S.H., Min C.W., Jo I.H., Bang K.H., Hyun D.-Y., Agrawal G.K., Rakwal R., Zargar S.M., Gupta R., et al. Ginseng (Panax sp.) proteomics: An update. Appl. Biol. Chem. 2017;60:311\u2013320. doi: 10.1007/s13765-017-0283-y.", "ArticleIdList": ["10.1007/s13765-017-0283-y"]}, {"Citation": "Li Z.H., Alex D., Siu S.O., Chu I.K., Renn J., Winkler C., Lou S., Tsui S.K., Zhao H.Y., Yan W.R., et al. Combined in vivo imaging and omics approaches reveal metabolism of icaritin and its glycosides in zebrafish larvae. Mol. BioSyst. 2011;7:2128\u20132138. doi: 10.1039/c1mb00001b.", "ArticleIdList": ["10.1039/c1mb00001b", "21445457"]}, {"Citation": "Hung M.W., Zhang Z.J., Li S., Lei B., Yuan S., Cui G.Z., Man Hoi P., Chan K., Lee S.M.Y. From omics to drug metabolism and high content screen of natural product in zebrafish: A new model for discovery of neuroactive compound. Evid.-Based Complement. Altern. Med. 2012;2012:605303. doi: 10.1155/2012/605303.", "ArticleIdList": ["10.1155/2012/605303", "PMC3420231", "22919414"]}, {"Citation": "Lao Y., Wang X., Xu N., Zhang H., Xu H. Application of proteomics to determine the mechanism of action of traditional Chinese medicine remedies. J. Ethnopharmacol. 2014;155:1\u20138. doi: 10.1016/j.jep.2014.05.022.", "ArticleIdList": ["10.1016/j.jep.2014.05.022", "24862488"]}, {"Citation": "Guan D., Chen Z. Challenges and recent advances in affinity purification of tag-free proteins. Biotechnol. Lett. 2014;36:1391\u20131406. doi: 10.1007/s10529-014-1509-2.", "ArticleIdList": ["10.1007/s10529-014-1509-2", "24658742"]}, {"Citation": "Novick D., Rubinstein M. Ligand affinity chromatography, an indispensable method for the purification of soluble cytokine receptors and binding proteins. Methods Mol. Biol. 2012;820:195\u2013214.", "ArticleIdList": ["22131033"]}, {"Citation": "Pfaunmiller E.L., Paulemond M.L., Dupper C.M., Hage D.S. Affinity monolith chromatography: A review of principles and recent analytical applications. Anal. Bioanal. Chem. 2013;405:2133\u20132145. doi: 10.1007/s00216-012-6568-4.", "ArticleIdList": ["10.1007/s00216-012-6568-4", "PMC3578177", "23187827"]}, {"Citation": "Rix U., Gridling M., Superti-Furga G. Compound immobilization and drug-affinity chromatography. Methods Mol. Biol. 2012;803:25\u201338.", "ArticleIdList": ["22065216"]}, {"Citation": "Wang H.Z., Chu Z.Z., Chen C.C., Cao A.C., Tong X., Ouyang C.B., Yuan Q.H., Wang M.N., Wu Z.K., Wang H.H., et al. Recombinant passenger proteins can be conveniently purified by one-step affinity chromatography. PLoS ONE. 2015;10:e0143598. doi: 10.1371/journal.pone.0143598.", "ArticleIdList": ["10.1371/journal.pone.0143598", "PMC4671538", "26641240"]}, {"Citation": "Zhang X., Wang T., Zhang H., Han B., Wang L., Kang J. Profiling of drug binding proteins by monolithic affinity chromatography in combination with liquid chromatography-tandem mass spectrometry. J. Chromatogr. A. 2014;1359:84\u201390. doi: 10.1016/j.chroma.2014.07.020.", "ArticleIdList": ["10.1016/j.chroma.2014.07.020", "25064533"]}, {"Citation": "Schenone M., Dancik V., Wagner B.K., Clemons P.A. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol. 2013;9:232\u2013240. doi: 10.1038/nchembio.1199.", "ArticleIdList": ["10.1038/nchembio.1199", "PMC5543995", "23508189"]}, {"Citation": "McFedries A., Schwaid A., Saghatelian A. Methods for the elucidation of protein-small molecule interactions. Chem. Biol. 2013;20:667\u2013673. doi: 10.1016/j.chembiol.2013.04.008.", "ArticleIdList": ["10.1016/j.chembiol.2013.04.008", "23706633"]}, {"Citation": "Rix U., Superti-Furga G. Target profiling of small molecules by chemical proteomics. Nat. Chem. Biol. 2009;5:616\u2013624. doi: 10.1038/nchembio.216.", "ArticleIdList": ["10.1038/nchembio.216", "19690537"]}, {"Citation": "Lee H., Lee J.W. Target identification for biologically active small molecules using chemical biology approaches. Arch. Pharm. Res. 2016;39:1193\u20131201. doi: 10.1007/s12272-016-0791-z.", "ArticleIdList": ["10.1007/s12272-016-0791-z", "27387321"]}, {"Citation": "Franken H., Mathieson T., Childs D., Sweetman G.M., Werner T., Togel I., Doce C., Gade S., Bantscheff M., Drewes G., et al. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat. Protoc. 2015;10:1567\u20131593. doi: 10.1038/nprot.2015.101.", "ArticleIdList": ["10.1038/nprot.2015.101", "26379230"]}, {"Citation": "Jafari R., Almqvist H., Axelsson H., Ignatushchenko M., Lundback T., Nordlund P., Martinez Molina D. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 2014;9:2100\u20132122. doi: 10.1038/nprot.2014.138.", "ArticleIdList": ["10.1038/nprot.2014.138", "25101824"]}, {"Citation": "Lomenick B., Hao R., Jonai N., Chin R.M., Aghajan M., Warburton S., Wang J., Wu R.P., Gomez F., Loo J.A., et al. Target identification using drug affinity responsive target stability (darts) Proc. Natl. Acad. Sci. USA. 2009;106:21984\u201321989. doi: 10.1073/pnas.0910040106.", "ArticleIdList": ["10.1073/pnas.0910040106", "PMC2789755", "19995983"]}, {"Citation": "Schirle M., Bantscheff M., Kuster B. Mass spectrometry-based proteomics in preclinical drug discovery. Chem. Biol. 2012;19:72\u201384. doi: 10.1016/j.chembiol.2012.01.002.", "ArticleIdList": ["10.1016/j.chembiol.2012.01.002", "22284356"]}, {"Citation": "Lomenick B., Olsen R.W., Huang J. Identification of direct protein targets of small molecules. ACS Chem. Biol. 2011;6:34\u201346. doi: 10.1021/cb100294v.", "ArticleIdList": ["10.1021/cb100294v", "PMC3031183", "21077692"]}, {"Citation": "Dejonghe W., Russinova E. Target identification strategies in plant chemical biology. Front. Plant Sci. 2014;5:352. doi: 10.3389/fpls.2014.00352.", "ArticleIdList": ["10.3389/fpls.2014.00352", "PMC4109434", "25104953"]}, {"Citation": "West G.M., Tucker C.L., Xu T., Park S.K., Han X., Yates J.R., 3rd, Fitzgerald M.C. Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements. Proc. Natl. Acad. Sci. USA. 2010;107:9078\u20139082. doi: 10.1073/pnas.1000148107.", "ArticleIdList": ["10.1073/pnas.1000148107", "PMC2889096", "20439767"]}, {"Citation": "West G.M., Tang L., Fitzgerald M.C. Thermodynamic analysis of protein stability and ligand binding using a chemical modification- and mass spectrometry-based strategy. Anal. Chem. 2008;80:4175\u20134185. doi: 10.1021/ac702610a.", "ArticleIdList": ["10.1021/ac702610a", "18457414"]}, {"Citation": "Jin L., Wang D., Gooden D.M., Ball C.H., Fitzgerald M.C. Targeted mass spectrometry-based approach for protein-ligand binding analyses in complex biological mixtures using a phenacyl bromide modification strategy. Anal. Chem. 2016;88:10987\u201310993. doi: 10.1021/acs.analchem.6b02658.", "ArticleIdList": ["10.1021/acs.analchem.6b02658", "27740755"]}, {"Citation": "Saxena C. Identification of protein binding partners of small molecules using label-free methods. Expert Opin. Drug Discov. 2016;11:1017\u20131025. doi: 10.1080/17460441.2016.1227316.", "ArticleIdList": ["10.1080/17460441.2016.1227316", "27554241"]}, {"Citation": "Strickland E.C., Geer M.A., Hong J., Fitzgerald M.C. False-positive rate determination of protein target discovery using a covalent modification- and mass spectrometry-based proteomics platform. J. Am. Soc. Mass Spectrom. 2014;25:132\u2013140. doi: 10.1007/s13361-013-0754-2.", "ArticleIdList": ["10.1007/s13361-013-0754-2", "PMC3880622", "24114261"]}, {"Citation": "Dearmond P.D., Xu Y., Strickland E.C., Daniels K.G., Fitzgerald M.C. Thermodynamic analysis of protein-ligand interactions in complex biological mixtures using a shotgun proteomics approach. J. Proteome Res. 2011;10:4948\u20134958. doi: 10.1021/pr200403c.", "ArticleIdList": ["10.1021/pr200403c", "PMC3208786", "21905665"]}, {"Citation": "Tran D.T., Adhikari J., Fitzgerald M.C. Stableisotope labeling with amino acids in cell culture (SILAC)-based strategy for proteome-wide thermodynamic analysis of protein-ligand binding interactions. Mol. Cell. Proteom. 2014;13:1800\u20131813. doi: 10.1074/mcp.M113.034702.", "ArticleIdList": ["10.1074/mcp.M113.034702", "PMC4083116", "24741112"]}, {"Citation": "Geiger T., Wisniewski J.R., Cox J., Zanivan S., Kruger M., Ishihama Y., Mann M. Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics. Nat. Protoc. 2011;6:147\u2013157. doi: 10.1038/nprot.2010.192.", "ArticleIdList": ["10.1038/nprot.2010.192", "21293456"]}, {"Citation": "Hoedt E., Zhang G., Neubert T.A. Stable isotope labeling by amino acids in cell culture (SILAC) for quantitative proteomics. Adv. Exp. Med. Biol. 2014;806:93\u2013106.", "ArticleIdList": ["24952180"]}, {"Citation": "Larance M., Bailly A.P., Pourkarimi E., Hay R.T., Buchanan G., Coulthurst S., Xirodimas D.P., Gartner A., Lamond A.I. Stable-isotope labeling with amino acids in nematodes. Nat. Methods. 2011;8:849\u2013851. doi: 10.1038/nmeth.1679.", "ArticleIdList": ["10.1038/nmeth.1679", "PMC3184259", "21874007"]}, {"Citation": "Ong S.E., Mann M. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) Nat. Protoc. 2006;1:2650\u20132660. doi: 10.1038/nprot.2006.427.", "ArticleIdList": ["10.1038/nprot.2006.427", "17406521"]}, {"Citation": "Zhang L., Jin J., Zhang L., Hu R., Gao L., Huo X., Liu D., Ma X., Wang C., Han J., et al. Quantitative analysis of differential protein expression in cervical carcinoma cells after zeylenone treatment by stable isotope labeling with amino acids in cell culture. J. Proteom. 2015;126:279\u2013287. doi: 10.1016/j.jprot.2015.06.012.", "ArticleIdList": ["10.1016/j.jprot.2015.06.012", "26130516"]}, {"Citation": "Martinez Molina D., Jafari R., Ignatushchenko M., Seki T., Larsson E.A., Dan C., Sreekumar L., Cao Y., Nordlund P. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 2013;341:84\u201387. doi: 10.1126/science.1233606.", "ArticleIdList": ["10.1126/science.1233606", "23828940"]}, {"Citation": "Schirle M., Jenkins J.L. Identifying compound efficacy targets in phenotypic drug discovery. Drug Discov. Today. 2016;21:82\u201389. doi: 10.1016/j.drudis.2015.08.001.", "ArticleIdList": ["10.1016/j.drudis.2015.08.001", "26272035"]}, {"Citation": "Tang H., Duggan S., Richardson P.L., Marin V., Warder S.E., McLoughlin S.M. Target identification of compounds from a cell viability phenotypic screen using a bead/lysate-based affinity capture platform. J. Biomol. Screen. 2016;21:201\u2013211. doi: 10.1177/1087057115622431.", "ArticleIdList": ["10.1177/1087057115622431", "26676096"]}, {"Citation": "Huber K.V., Olek K.M., Muller A.C., Tan C.S., Bennett K.L., Colinge J., Superti-Furga G. Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling. Nat. Methods. 2015;12:1055\u20131057. doi: 10.1038/nmeth.3590.", "ArticleIdList": ["10.1038/nmeth.3590", "PMC4629415", "26389571"]}, {"Citation": "Reinhard F.B., Eberhard D., Werner T., Franken H., Childs D., Doce C., Savitski M.F., Huber W., Bantscheff M., Savitski M.M., et al. Thermal proteome profiling monitors ligand interactions with cellular membrane proteins. Nat. Methods. 2015;12:1129\u20131131. doi: 10.1038/nmeth.3652.", "ArticleIdList": ["10.1038/nmeth.3652", "26524241"]}, {"Citation": "Savitski M.M., Reinhard F.B., Franken H., Werner T., Savitski M.F., Eberhard D., Martinez Molina D., Jafari R., Dovega R.B., Klaeger S., et al. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science. 2014;346:1255784. doi: 10.1126/science.1255784.", "ArticleIdList": ["10.1126/science.1255784", "25278616"]}, {"Citation": "Becher I., Werner T., Doce C., Zaal E.A., Togel I., Khan C.A., Rueger A., Muelbaier M., Salzer E., Berkers C.R., et al. Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat. Nat. Chem. Biol. 2016;12:908\u2013910. doi: 10.1038/nchembio.2185.", "ArticleIdList": ["10.1038/nchembio.2185", "27669419"]}, {"Citation": "Mateus A., Maatta T.A., Savitski M.M. Thermal proteome profiling: Unbiased assessment of protein state through heat-induced stability changes. Proteome Sci. 2016;15:13. doi: 10.1186/s12953-017-0122-4.", "ArticleIdList": ["10.1186/s12953-017-0122-4", "PMC5482948", "28652855"]}, {"Citation": "Ho C.H., Magtanong L., Barker S.L., Gresham D., Nishimura S., Natarajan P., Koh J.L.Y., Porter J., Gray C.A., Andersen R.J., et al. A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat. Biotechnol. 2009;27:369\u2013377. doi: 10.1038/nbt.1534.", "ArticleIdList": ["10.1038/nbt.1534", "PMC3856559", "19349972"]}, {"Citation": "Jung H.J., Kwon H.J. Target deconvolution of bioactive small molecules: The heart of chemical biology and drug discovery. Arch. Pharm. Res. 2015;38:1627\u20131641. doi: 10.1007/s12272-015-0618-3.", "ArticleIdList": ["10.1007/s12272-015-0618-3", "26040984"]}, {"Citation": "Bassik M.C., Kampmann M., Lebbink R.J., Wang S., Hein M.Y., Poser I., Weibezahn J., Horlbeck M.A., Chen S., Mann M., et al. A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility. Cell. 2013;152:909\u2013922. doi: 10.1016/j.cell.2013.01.030.", "ArticleIdList": ["10.1016/j.cell.2013.01.030", "PMC3652613", "23394947"]}, {"Citation": "Shalem O., Sanjana N.E., Hartenian E., Shi X., Scott D.A., Mikkelson T., Heckl D., Ebert B.L., Root D.E., Doench J.G., et al. Genome-scale crispr-cas9 knockout screening in human cells. Science. 2014;343:84\u201387. doi: 10.1126/science.1247005.", "ArticleIdList": ["10.1126/science.1247005", "PMC4089965", "24336571"]}, {"Citation": "Kasap C., Elemento O., Kapoor T.M. Drugtargetseqr: A genomics- and CRISPR-Cas9-based method to analyze drug targets. Nat. Chem. Biol. 2014;10:626\u2013628. doi: 10.1038/nchembio.1551.", "ArticleIdList": ["10.1038/nchembio.1551", "PMC4123312", "24929528"]}, {"Citation": "Ipsaro J.J., Shen C., Arai E., Xu Y., Kinney J.B., Joshua-Tor L., Vakoc C.R., Shi J. Rapid generation of drug-resistance alleles at endogenous loci using CRISPR-Cas9 indel mutagenesis. PLoS ONE. 2017;12:e0172177. doi: 10.1371/journal.pone.0172177.", "ArticleIdList": ["10.1371/journal.pone.0172177", "PMC5322889", "28231254"]}, {"Citation": "Neggers J.E., Vercruysse T., Jacquemyn M., Vanstreels E., Baloglu E., Shacham S., Crochiere M., Landesman Y., Daelemans D. Identifying drug-target selectivity of small-molecule CRM1/XPO1 inhibitors by CRISPR/Cas9 genome editing. Chem. Biol. 2015;22:107\u2013116. doi: 10.1016/j.chembiol.2014.11.015.", "ArticleIdList": ["10.1016/j.chembiol.2014.11.015", "25579209"]}, {"Citation": "Liu X., Locasale J.W. Metabolomics: A primer. Trends Biochem. Sci. 2017;42:274\u2013284. doi: 10.1016/j.tibs.2017.01.004.", "ArticleIdList": ["10.1016/j.tibs.2017.01.004", "PMC5376220", "28196646"]}, {"Citation": "Clish C.B. Metabolomics: An emerging but powerful tool for precision medicine. Cold Spring Harb. Mol. Case Stud. 2015;1:a000588. doi: 10.1101/mcs.a000588.", "ArticleIdList": ["10.1101/mcs.a000588", "PMC4850886", "27148576"]}, {"Citation": "Nicholson J.K., Lindon J.C. Systems biology: Metabonomics. Nature. 2008;455:7216. doi: 10.1038/4551054a.", "ArticleIdList": ["10.1038/4551054a", "18948945"]}, {"Citation": "Perez-Pinera P., Ousterout D.G., Gersbach C.A. Advances in targeted genome editing. Curr. Opin. Chem. Biol. 2012;16:268\u2013277. doi: 10.1016/j.cbpa.2012.06.007.", "ArticleIdList": ["10.1016/j.cbpa.2012.06.007", "PMC3424393", "22819644"]}, {"Citation": "Siminovitch L. Genetic manipulation: Now is the time to consider controls. Sci. Forum. 1973;6:7\u201311.", "ArticleIdList": ["11662962"]}, {"Citation": "Yarmush M.L., Banta S. Metabolic engineering: Advances in modeling and intervention in health and disease. Ann. Rev. Biomed. Eng. 2003;5:349\u2013381. doi: 10.1146/annurev.bioeng.5.031003.163247.", "ArticleIdList": ["10.1146/annurev.bioeng.5.031003.163247", "14527316"]}, {"Citation": "Yan T., Fu Q., Wang J., Ma S. UPLC-MS/MS determination of ephedrine, methylephedrine, amygdalin and glycyrrhizic acid in beagle plasma and its application to a pharmacokinetic study after oral administration of Ma Huang Tang. Drug. Test. Anal. 2015;7:158\u2013163. doi: 10.1002/dta.1635.", "ArticleIdList": ["10.1002/dta.1635", "24824649"]}, {"Citation": "Ekow Thomford N., Dzobo K., Adu F., Chirikure S., Wonkam A., Dandara C. Bush mint (Hyptis suaveolens) and spreading hogweed (Boerhavia diffusa) medicinal plant extracts differentially affect activities of CYP1A2, CYP2D6 and CYP3A4 enzymes. J. Ethnopharmacol. 2018;211:58\u201369. doi: 10.1016/j.jep.2017.09.023.", "ArticleIdList": ["10.1016/j.jep.2017.09.023", "28942133"]}, {"Citation": "Xie G., Plumb R., Su M., Xu Z., Zhao A., Qiu M., Long X., Liu Z., Jia W. Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research. J. Sep. Sci. 2008;31:1015\u20131026. doi: 10.1002/jssc.200700650.", "ArticleIdList": ["10.1002/jssc.200700650", "18338405"]}, {"Citation": "Park H.-W., In G., Kim J.-H., Cho B.-G., Han G.-H., Chang I.-M. Metabolomic approach for discrimination of processed ginseng genus (Panax ginseng and Panax quinquefolius) using UPLC-QTOF MS. J. Ginseng Res. 2014;38:59\u201365. doi: 10.1016/j.jgr.2013.11.011.", "ArticleIdList": ["10.1016/j.jgr.2013.11.011", "PMC3915342", "24558312"]}, {"Citation": "Korotcov A., Tkachenko V., Russo D.P., Ekins S. Comparison of deep learning with multiple machine learning methods and metrics using diverse drug discovery data sets. Mol. Pharm. 2017;14:4462\u20134475. doi: 10.1021/acs.molpharmaceut.7b00578.", "ArticleIdList": ["10.1021/acs.molpharmaceut.7b00578", "PMC5741413", "29096442"]}, {"Citation": "Oprea T.I., Matter H. Integrating virtual screening in lead discovery. Curr. Opin. Chem. Biol. 2004;8:349\u2013358. doi: 10.1016/j.cbpa.2004.06.008.", "ArticleIdList": ["10.1016/j.cbpa.2004.06.008", "15288243"]}, {"Citation": "Beck A., Eberherr C., Hagemann M., Cairo S., Haberle B., Vokuhl C., von Schweinitz D., Kappler R. Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma. Cancer Biol. Ther. 2016;17:1168\u20131176. doi: 10.1080/15384047.2016.1235664.", "ArticleIdList": ["10.1080/15384047.2016.1235664", "PMC5137489", "27635950"]}, {"Citation": "Brum A.M., van de Peppel J., van der Leije C.S., Schreuders-Koedam M., Eijken M., van der Eerden B.C., van Leeuwen J.P. Connectivity map-based discovery of parbendazole reveals targetable human osteogenic pathway. Proc. Natl. Acad. Sci. USA. 2015;112:12711\u201312716. doi: 10.1073/pnas.1501597112.", "ArticleIdList": ["10.1073/pnas.1501597112", "PMC4611615", "26420877"]}, {"Citation": "Cheng J., Yang L., Kumar V., Agarwal P. Systematic evaluation of connectivity map for disease indications. Genome Med. 2014;6:95. doi: 10.1186/s13073-014-0095-1.", "ArticleIdList": ["10.1186/s13073-014-0095-1", "PMC4278345", "25606058"]}, {"Citation": "Lamb J. The connectivity map: A new tool for biomedical research. Nat. Rev. Cancer. 2007;7:54\u201360. doi: 10.1038/nrc2044.", "ArticleIdList": ["10.1038/nrc2044", "17186018"]}, {"Citation": "Lamb J., Crawford E.D., Peck D., Modell J.W., Blat I.C., Wrobel M.J., Lerner J., Brunet J.P., Subramanian A., Ross K.N., et al. The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313:1929\u20131935. doi: 10.1126/science.1132939.", "ArticleIdList": ["10.1126/science.1132939", "17008526"]}, {"Citation": "Hahn C.K., Berchuck J.E., Ross K.N., Kakoza R.M., Clauser K., Schinzel A.C., Ross L., Galinsky I., Davis T.N., Silver S.J., et al. Proteomic and genetic approaches identify Syk as an AML target. Cancer Cell. 2009;16:281\u2013294. doi: 10.1016/j.ccr.2009.08.018.", "ArticleIdList": ["10.1016/j.ccr.2009.08.018", "PMC2803063", "19800574"]}, {"Citation": "Nair M., Sandhu S.S., Sharma A.K. Prognostic and predictive biomarkers in cancer. Curr. Cancer Drug Targets. 2014;14:477\u2013504. doi: 10.2174/1568009614666140506111118.", "ArticleIdList": ["10.2174/1568009614666140506111118", "24807144"]}, {"Citation": "Narayanan R. Druggable cancer secretome: Neoplasm-associated traits. Cancer Genom. Proteom. 2015;12:119\u2013131.", "ArticleIdList": ["25977171"]}, {"Citation": "Roti G., Stegmaier K. Genetic and proteomic approaches to identify cancer drug targets. Br. J. Cancer. 2012;106:254\u2013261. doi: 10.1038/bjc.2011.543.", "ArticleIdList": ["10.1038/bjc.2011.543", "PMC3262130", "22166799"]}, {"Citation": "Verma M., Wright G.L., Jr., Hanash S.M., Gopal-Srivastava R., Srivastava S. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann. N. Y. Acad. Sci. 2001;945:103\u2013115. doi: 10.1111/j.1749-6632.2001.tb03870.x.", "ArticleIdList": ["10.1111/j.1749-6632.2001.tb03870.x", "11708463"]}, {"Citation": "Awale M., Visini R., Probst D., Arus-Pous J., Reymond J.L. Chemical space: Big data challenge for molecular diversity. Chimia. 2017;71:661\u2013666. doi: 10.2533/chimia.2017.661.", "ArticleIdList": ["10.2533/chimia.2017.661", "29070411"]}, {"Citation": "Denny J.C., Van Driest S.L., Wei W.Q., Roden D.M. The influence of big (clinical) data and genomics on precision medicine and drug development. Clin. Pharmacol. Ther. 2018;103:409\u2013418. doi: 10.1002/cpt.951.", "ArticleIdList": ["10.1002/cpt.951", "PMC5805632", "29171014"]}, {"Citation": "Singh G., Schulthess D., Hughes N., Vannieuwenhuyse B., Kalra D. Real world big data for clinical research and drug development. Drug Discov. Today. 2018;23:650\u2013660. doi: 10.1016/j.drudis.2017.12.002.", "ArticleIdList": ["10.1016/j.drudis.2017.12.002", "29294362"]}, {"Citation": "Bento A.P., Gaulton A., Hersey A., Bellis L.J., Chambers J., Davies M., Kruger F.A., Light Y., Mak L., McGlinchey S., et al. The ChEMBL bioactivity database: An update. Nucleic Acids Res. 2014;42:D1083\u2013D1090. doi: 10.1093/nar/gkt1031.", "ArticleIdList": ["10.1093/nar/gkt1031", "PMC3965067", "24214965"]}, {"Citation": "Gaulton A., Bellis L.J., Bento A.P., Chambers J., Davies M., Hersey A., Light Y., McGlinchey S., Michalovich D., Al-Lazikani B., et al. Chembl: A large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012;40:D1100\u2013D1107. doi: 10.1093/nar/gkr777.", "ArticleIdList": ["10.1093/nar/gkr777", "PMC3245175", "21948594"]}, {"Citation": "Gaulton A., Hersey A., Nowotka M., Bento A.P., Chambers J., Mendez D., Mutowo P., Atkinson F., Bellis L.J., Cibrian-Uhalte E., et al. The ChEMBL database in 2017. Nucleic Acids Res. 2017;45:D945\u2013D954. doi: 10.1093/nar/gkw1074.", "ArticleIdList": ["10.1093/nar/gkw1074", "PMC5210557", "27899562"]}, {"Citation": "Kruger F.A., Rostom R., Overington J.P. Mapping small molecule binding data to structural domains. BMC Bioinform. 2012;13:S11", "ArticleIdList": ["PMC3521243", "23282026"]}, {"Citation": "Roos D.S. Computational biology. Bioinformatics\u2014Trying to swim in a sea of data. Science. 2001;291:1260\u20131261. doi: 10.1126/science.291.5507.1260.", "ArticleIdList": ["10.1126/science.291.5507.1260", "11233452"]}, {"Citation": "Jennings A., Tennant M. Discovery strategies in a pharmaceutical setting: The application of computational techniques. Expert Opin. Drug Discov. 2006;1:709\u2013721. doi: 10.1517/17460441.1.7.709.", "ArticleIdList": ["10.1517/17460441.1.7.709", "23495995"]}, {"Citation": "Chen Y.P., Chen F. Identifying targets for drug discovery using bioinformatics. Expert Opin. Ther. Targets. 2008;12:383\u2013389. doi: 10.1517/14728222.12.4.383.", "ArticleIdList": ["10.1517/14728222.12.4.383", "18348676"]}, {"Citation": "Segal M.R., Xiong H., Bengtsson H., Bourgon R., Gentleman R. Querying genomic databases: Refining the connectivity map. Stat. Appl. Genet. Mol. Biol. 2012;11 doi: 10.2202/1544-6115.1715.", "ArticleIdList": ["10.2202/1544-6115.1715", "22499690"]}, {"Citation": "Kim R.S., Goossens N., Hoshida Y. Use of big data in drug development for precision medicine. Expert Rev. Precis. Med. Drug Dev. 2016;1:245\u2013253. doi: 10.1080/23808993.2016.1174062.", "ArticleIdList": ["10.1080/23808993.2016.1174062", "PMC4943760", "27430024"]}, {"Citation": "Cappon G.D. Nonclinical support of pediatric drug development in a global context: An industry perspective. Birth Defects Res. Part B Dev. Reprod. Toxicol. 2011;92:269\u2013272. doi: 10.1002/bdrb.20303.", "ArticleIdList": ["10.1002/bdrb.20303", "21594976"]}, {"Citation": "Kaneko T., Cooper C., Mdluli K. Challenges and opportunities in developing novel drugs for TB. Future Med. Chem. 2011;3:1373\u20131400. doi: 10.4155/fmc.11.115.", "ArticleIdList": ["10.4155/fmc.11.115", "21879843"]}, {"Citation": "Morford L.L., Bowman C.J., Blanset D.L., Bogh I.B., Chellman G.J., Halpern W.G., Weinbauer G.F., Coogan T.P. Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: Strategy, challenges, current practices. Birth Defects Res. Part B Dev. Reprod. Toxicol. 2011;92:359\u2013380. doi: 10.1002/bdrb.20305.", "ArticleIdList": ["10.1002/bdrb.20305", "21770023"]}, {"Citation": "Beggs N.F., Dobrovolny H.M. Determining drug efficacy parameters for mathematical models of influenza. J. Biol. Dyn. 2015;9:332\u2013346. doi: 10.1080/17513758.2015.1052764.", "ArticleIdList": ["10.1080/17513758.2015.1052764", "26056712"]}, {"Citation": "Hwang W., Choi J., Kwon M., Lee D. Context-specific functional module based drug efficacy prediction. BMC Bioinform. 2016;17(Suppl. 6) doi: 10.1186/s12859-016-1078-6.", "ArticleIdList": ["10.1186/s12859-016-1078-6", "PMC4965733", "27490093"]}, {"Citation": "Jimenez-Diaz M.B., Viera S., Fernandez-Alvaro E., Angulo-Barturen I. Animal models of efficacy to accelerate drug discovery in malaria. Parasitology. 2014;141:93\u2013103. doi: 10.1017/S0031182013000991.", "ArticleIdList": ["10.1017/S0031182013000991", "23789594"]}, {"Citation": "Nelson M.R., Johnson T., Warren L., Hughes A.R., Chissoe S.L., Xu C.F., Waterworth D.M. The genetics of drug efficacy: Opportunities and challenges. Nat. Rev. Genet. 2016;17:197\u2013206. doi: 10.1038/nrg.2016.12.", "ArticleIdList": ["10.1038/nrg.2016.12", "26972588"]}, {"Citation": "Tsugawa J., Onozawa R., Fukae J., Mishima T., Fujioka S., Tsuboi Y. Impact of insufficient drug efficacy of antiparkinson agents on patient\u2019s quality of life: A cross-sectional study. BMC Neurol. 2015;15:105. doi: 10.1186/s12883-015-0360-y.", "ArticleIdList": ["10.1186/s12883-015-0360-y", "PMC4491278", "26143184"]}, {"Citation": "Gange S.J., Golub E.T. From smallpox to big data: The next 100 years of epidemiologic methods. Am. J. Epidemiol. 2016;183:423\u2013426. doi: 10.1093/aje/kwv150.", "ArticleIdList": ["10.1093/aje/kwv150", "26443419"]}, {"Citation": "Docherty A.B., Lone N.I. Exploiting big data for critical care research. Curr. Opin. Crit. Care. 2015;21:467\u2013472. doi: 10.1097/MCC.0000000000000228.", "ArticleIdList": ["10.1097/MCC.0000000000000228", "26348424"]}, {"Citation": "Greene C.S., Tan J., Ung M., Moore J.H., Cheng C. Big data bioinformatics. J. Cell. Physiol. 2014;229:1896\u20131900. doi: 10.1002/jcp.24662.", "ArticleIdList": ["10.1002/jcp.24662", "PMC5604462", "24799088"]}, {"Citation": "Tan S.S., Gao G., Koch S. Big data and analytics in healthcare. Methods Inf. Med. 2015;54:546\u2013547. doi: 10.3414/ME15-06-1001.", "ArticleIdList": ["10.3414/ME15-06-1001", "26577624"]}, {"Citation": "Wasser T., Haynes K., Barron J., Cziraky M. Using \u2018big data\u2019 to validate claims made in the pharmaceutical approval process. J. Med. Econ. 2015;18:1013\u20131019. doi: 10.3111/13696998.2015.1108919.", "ArticleIdList": ["10.3111/13696998.2015.1108919", "26548546"]}, {"Citation": "Reshef D.N., Reshef Y.A., Finucane H.K., Grossman S.R., McVean G., Turnbaugh P.J., Lander E.S., Mitzenmacher M., Sabeti P.C. Detecting novel associations in large data sets. Science. 2011;334:1518\u20131524. doi: 10.1126/science.1205438.", "ArticleIdList": ["10.1126/science.1205438", "PMC3325791", "22174245"]}, {"Citation": "Omberg L., Ellrott K., Yuan Y., Kandoth C., Wong C., Kellen M.R., Friend S.H., Stuart J., Liang H., Margolin A.A. Enabling transparent and collaborative computational analysis of 12 tumor types within the cancer genome atlas. Nat. Genet. 2013;45:1121\u20131126. doi: 10.1038/ng.2761.", "ArticleIdList": ["10.1038/ng.2761", "PMC3950337", "24071850"]}, {"Citation": "Chen R., Mias G.I., Li-Pook-Than J., Jiang L., Lam H.Y., Chen R., Miriami E., Karczewski K.J., Hariharan M., Dewey F.E., et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148:1293\u20131307. doi: 10.1016/j.cell.2012.02.009.", "ArticleIdList": ["10.1016/j.cell.2012.02.009", "PMC3341616", "22424236"]}, {"Citation": "Chapman T. Lab automation and robotics: Automation on the move. Nature. 2003;421:661\u2013666. doi: 10.1038/421661a.", "ArticleIdList": ["10.1038/421661a", "12571603"]}, {"Citation": "King R.D., Rowland J., Oliver S.G., Young M., Aubrey W., Byrne E., Liakata M., Markham M., Pir P., Soldatova L.N., et al. The automation of science. Science. 2009;324:85\u201389. doi: 10.1126/science.1165620.", "ArticleIdList": ["10.1126/science.1165620", "19342587"]}, {"Citation": "Sparkes A., Aubrey W., Byrne E., Clare A., Khan M.N., Liakata M., Markham M., Rowland J., Soldatova L.N., Whelan K.E., et al. Towards robot scientists for autonomous scientific discovery. Autom. Exp. 2010;2:1. doi: 10.1186/1759-4499-2-1.", "ArticleIdList": ["10.1186/1759-4499-2-1", "PMC2813846", "20119518"]}, {"Citation": "Meanwell N.A. Improving drug design: An update on recent applications of efficiency metrics, strategies for replacing problematic elements, and compounds in non-traditional drug space. Chem. Res. Toxicol. 2016;29:564\u2013616. doi: 10.1021/acs.chemrestox.6b00043.", "ArticleIdList": ["10.1021/acs.chemrestox.6b00043", "26974882"]}, {"Citation": "MacConnell A.B., Price A.K., Paegel B.M. An integrated microfluidic processor for DNA-encoded combinatorial library functional screening. ACS Comb. Sci. 2017;19:181\u2013192. doi: 10.1021/acscombsci.6b00192.", "ArticleIdList": ["10.1021/acscombsci.6b00192", "PMC5350604", "28199790"]}, {"Citation": "Baranczak A., Tu N.P., Marjanovic J., Searle P.A., Vasudevan A., Djuric S.W. Integrated platform for expedited synthesis-purification-testing of small molecule libraries. ACS Med. Chem. Lett. 2017;8:461\u2013465. doi: 10.1021/acsmedchemlett.7b00054.", "ArticleIdList": ["10.1021/acsmedchemlett.7b00054", "PMC5392760", "28435537"]}, {"Citation": "Gupta A., Muller A.T., Huisman B.J.H., Fuchs J.A., Schneider P., Schneider G. Generative recurrent networks for de novo drug design. Mol. Inform. 2017 doi: 10.1002/minf.201700111.", "ArticleIdList": ["10.1002/minf.201700111", "PMC5836943", "29095571"]}, {"Citation": "Merk D., Friedrich L., Grisoni F., Schneider G. De novo design of bioactive small molecules by artificial intelligence. Mol. Inform. 2018 doi: 10.1002/minf.201700153.", "ArticleIdList": ["10.1002/minf.201700153", "PMC5838524", "29319225"]}, {"Citation": "Zhang L., Tan J., Han D., Zhu H. From machine learning to deep learning: Progress in machine intelligence for rational drug discovery. Drug Discov. Today. 2017;22:1680\u20131685. doi: 10.1016/j.drudis.2017.08.010.", "ArticleIdList": ["10.1016/j.drudis.2017.08.010", "28881183"]}, {"Citation": "Duch W., Swaminathan K., Meller J. Artificial intelligence approaches for rational drug design and discovery. Curr. Pharm. Des. 2007;13:1497\u20131508. doi: 10.2174/138161207780765954.", "ArticleIdList": ["10.2174/138161207780765954", "17504169"]}, {"Citation": "Esch E.W., Bahinski A., Huh D. Organs-on-chips at the frontiers of drug discovery. Nat. Rev. Drug Discov. 2015;14:248\u2013260. doi: 10.1038/nrd4539.", "ArticleIdList": ["10.1038/nrd4539", "PMC4826389", "25792263"]}, {"Citation": "Eglen R.M., Randle D.H. Drug discovery goes three-dimensional: Goodbye to flat high-throughput screening? Assay Drug Dev. Technol. 2015;13:262\u2013265. doi: 10.1089/adt.2015.647.", "ArticleIdList": ["10.1089/adt.2015.647", "26121065"]}, {"Citation": "Ozdemir V., Patrinos G.P. David bowie and the art of slow innovation: A fast-second winner strategy for biotechnology and precision medicine global development. Omics. 2017;21:633\u2013637. doi: 10.1089/omi.2017.0148.", "ArticleIdList": ["10.1089/omi.2017.0148", "29064337"]}, {"Citation": "Burke M.D., Lalic G. Teaching target-oriented and diversity-oriented organic synthesis at Harvard University. Chem. Biol. 2002;9:535\u2013541. doi: 10.1016/S1074-5521(02)00143-6.", "ArticleIdList": ["10.1016/S1074-5521(02)00143-6", "12031659"]}, {"Citation": "Schreiber S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science. 2000;287:1964\u20131969. doi: 10.1126/science.287.5460.1964.", "ArticleIdList": ["10.1126/science.287.5460.1964", "10720315"]}, {"Citation": "Maier M.E. Design and synthesis of analogues of natural products. Org. Biomol. Chem. 2015;13:5302\u20135343. doi: 10.1039/C5OB00169B.", "ArticleIdList": ["10.1039/C5OB00169B", "25829247"]}, {"Citation": "Basu S., Ellinger B., Rizzo S., Deraeve C., Schurmann M., Preut H., Arndt H.D., Waldmann H. Biology-oriented synthesis of a natural-product inspired oxepane collection yields a small-molecule activator of the Wnt-pathway. Proc. Natl. Acad. Sci. USA. 2011;108:6805\u20136810. doi: 10.1073/pnas.1015269108.", "ArticleIdList": ["10.1073/pnas.1015269108", "PMC3084053", "21415367"]}, {"Citation": "Kaiser M., Wetzel S., Kumar K., Waldmann H. Biology-inspired synthesis of compound libraries. Cell. Mol. Life Sci. 2008;65:1186\u20131201. doi: 10.1007/s00018-007-7492-1.", "ArticleIdList": ["10.1007/s00018-007-7492-1", "18193390"]}, {"Citation": "Wetzel S., Bon R.S., Kumar K., Waldmann H. Biology-oriented synthesis. Angew. Chem. Int. Ed. Engl. 2011;50:10800\u201310826. doi: 10.1002/anie.201007004.", "ArticleIdList": ["10.1002/anie.201007004", "22038946"]}, {"Citation": "Wender P.A., Quiroz R.V., Stevens M.C. Function through synthesis-informed design. Acc. Chem. Res. 2015;48:752\u2013760. doi: 10.1021/acs.accounts.5b00004.", "ArticleIdList": ["10.1021/acs.accounts.5b00004", "PMC4415040", "25742599"]}, {"Citation": "Wender P.A., Verma V.A., Paxton T.J., Pillow T.H. Function-oriented synthesis, step economy, and drug design. Acc. Chem. Res. 2008;41:40\u201349. doi: 10.1021/ar700155p.", "ArticleIdList": ["10.1021/ar700155p", "18159936"]}, {"Citation": "Zhu Q., Sun Y., Challa S., Ding Y., Lajiness M.S., Wild D.J. Semantic inference using chemogenomics data for drug discovery. BMC Bioinform. 2011;12:256. doi: 10.1186/1471-2105-12-256.", "ArticleIdList": ["10.1186/1471-2105-12-256", "PMC3225082", "21699718"]}, {"Citation": "White D., Wilson R.C. Generative models for chemical structures. J. Chem. Inf. Model. 2010;50:1257\u20131274. doi: 10.1021/ci9004089.", "ArticleIdList": ["10.1021/ci9004089", "20666408"]}, {"Citation": "Rubio D.M., Schoenbaum E.E., Lee L.S., Schteingart D.E., Marantz P.R., Anderson K.E., Platt L.D., Baez A., Esposito K. Defining translational research: Implications for training. Acad. Med. 2010;85:470\u2013475. doi: 10.1097/ACM.0b013e3181ccd618.", "ArticleIdList": ["10.1097/ACM.0b013e3181ccd618", "PMC2829707", "20182120"]}, {"Citation": "Jing Y., Bian Y., Hu Z., Wang L., Xie X.S. Deep learning for drug design: An artificial intelligence paradigm for drug discovery in the big data era. AAPS J. 2018;20:58. doi: 10.1208/s12248-018-0210-0.", "ArticleIdList": ["10.1208/s12248-018-0210-0", "PMC6608578", "29603063"]}, {"Citation": "Reutlinger M., Rodrigues T., Schneider P., Schneider G. Combining on-chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands. Angew. Chem. Int. Ed. Engl. 2014;53:582\u2013585. doi: 10.1002/anie.201307786.", "ArticleIdList": ["10.1002/anie.201307786", "24282133"]}, {"Citation": "Schneider G. Automating drug discovery. Nat. Rev. Drug Discov. 2018;17:97\u2013113. doi: 10.1038/nrd.2017.232.", "ArticleIdList": ["10.1038/nrd.2017.232", "29242609"]}, {"Citation": "Reutlinger M., Rodrigues T., Schneider P., Schneider G. Multi-objective molecular de novo design by adaptive fragment prioritization. Angew. Chem. Int. Ed. Engl. 2014;53:4244\u20134248. doi: 10.1002/anie.201310864.", "ArticleIdList": ["10.1002/anie.201310864", "24623390"]}, {"Citation": "Schneider P., Rothlisberger M., Reker D., Schneider G. Spotting and designing promiscuous ligands for drug discovery. Chem. Commun. 2016;52:1135\u20131138. doi: 10.1039/C5CC07506H.", "ArticleIdList": ["10.1039/C5CC07506H", "26602698"]}, {"Citation": "Wang L., Wu Y., Deng Y., Kim B., Pierce L., Krilov G., Lupyan D., Robinson S., Dahlgren M.K., Greenwood J., et al. Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J. Am. Chem. Soc. 2015;137:2695\u20132703. doi: 10.1021/ja512751q.", "ArticleIdList": ["10.1021/ja512751q", "25625324"]}, {"Citation": "Besnard J., Ruda G.F., Setola V., Abecassis K., Rodriguiz R.M., Huang X.P., Norval S., Sassano M.F., Shin A.I., Webster L.A., et al. Automated design of ligands to polypharmacological profiles. Nature. 2012;492:215\u2013220. doi: 10.1038/nature11691.", "ArticleIdList": ["10.1038/nature11691", "PMC3653568", "23235874"]}, {"Citation": "Koppitz M., Eis K. Automated medicinal chemistry. Drug Discov. Today. 2006;11:561\u2013568. doi: 10.1016/j.drudis.2006.04.005.", "ArticleIdList": ["10.1016/j.drudis.2006.04.005", "16713909"]}, {"Citation": "Sutherland J.D., Tu N.P., Nemcek T.A., Searle P.A., Hochlowski J.E., Djuric S.W., Pan J.Y. An automated synthesis-purification-sample-management platform for the accelerated generation of pharmaceutical candidates. J. Lab. Autom. 2014;19:176\u2013182. doi: 10.1177/2211068213516325.", "ArticleIdList": ["10.1177/2211068213516325", "24352687"]}, {"Citation": "Godfrey A.G., Masquelin T., Hemmerle H. A remote-controlled adaptive medchem lab: An innovative approach to enable drug discovery in the 21st century. Drug Discov. Today. 2013;18:795\u2013802. doi: 10.1016/j.drudis.2013.03.001.", "ArticleIdList": ["10.1016/j.drudis.2013.03.001", "23523957"]}, {"Citation": "Nicolaou C.A., Watson I.A., Hu H., Wang J. The proximal lilly collection: Mapping, exploring and exploiting feasible chemical space. J. Chem. Inf. Model. 2016;56:1253\u20131266. doi: 10.1021/acs.jcim.6b00173.", "ArticleIdList": ["10.1021/acs.jcim.6b00173", "27286472"]}, {"Citation": "Li J., Ballmer S.G., Gillis E.P., Fujii S., Schmidt M.J., Palazzolo A.M., Lehmann J.W., Morehouse G.F., Burke M.D. Synthesis of many different types of organic small molecules using one automated process. Science. 2015;347:1221\u20131226. doi: 10.1126/science.aaa5414.", "ArticleIdList": ["10.1126/science.aaa5414", "PMC4687482", "25766227"]}, {"Citation": "Stalder R., Roth G.P. Preparative microfluidic electrosynthesis of drug metabolites. ACS Med. Chem. Lett. 2013;4:1119\u20131123. doi: 10.1021/ml400316p.", "ArticleIdList": ["10.1021/ml400316p", "PMC4027460", "24900614"]}, {"Citation": "Genovino J., Sames D., Hamann L.G., Toure B.B. Accessing drug metabolites via transition-metal catalyzed c-h oxidation: The liver as synthetic inspiration. Angew. Chem. Int. Ed. Engl. 2016;55:14218\u201314238. doi: 10.1002/anie.201602644.", "ArticleIdList": ["10.1002/anie.201602644", "27723189"]}, {"Citation": "LaPorte T.L., Wang C. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients. Curr. Opin. Drug Discov. Dev. 2007;10:738\u2013745.", "ArticleIdList": ["17987525"]}, {"Citation": "Chin P., Barney W.S., Pindzola B.A. Microstructured reactors as tools for the intensification of pharmaceutical reactions and processes. Curr. Opin. Drug Discov. Dev. 2009;12:848\u2013861.", "ArticleIdList": ["19894194"]}, {"Citation": "Saaby S., Knudsen K.R., Ladlow M., Ley S.V. The use of a continuous flow-reactor employing a mixed hydrogen-liquid flow stream for the efficient reduction of imines to amines. Chem. Commun. 2005:2909\u20132911. doi: 10.1039/b504854k.", "ArticleIdList": ["10.1039/b504854k", "15957022"]}, {"Citation": "Brzozowski M., O\u2019Brien M., Ley S.V., Polyzos A. Flow chemistry: Intelligent processing of gas-liquid transformations using a tube-in-tube reactor. Acc. Chem. Res. 2015;48:349\u2013362. doi: 10.1021/ar500359m.", "ArticleIdList": ["10.1021/ar500359m", "25611216"]}, {"Citation": "Loskill P., Sezhian T., Tharp K.M., Lee-Montiel F.T., Jeeawoody S., Reese W.M., Zushin P.H., Stahl A., Healy K.E. Wat-on-a-chip: A physiologically relevant microfluidic system incorporating white adipose tissue. Lab Chip. 2017;17:1645\u20131654. doi: 10.1039/C6LC01590E.", "ArticleIdList": ["10.1039/C6LC01590E", "PMC5688242", "28418430"]}, {"Citation": "Eyer K., Stratz S., Kuhn P., Kuster S.K., Dittrich P.S. Implementing enzyme-linked immunosorbent assays on a microfluidic chip to quantify intracellular molecules in single cells. Anal. Chem. 2013;85:3280\u20133287. doi: 10.1021/ac303628j.", "ArticleIdList": ["10.1021/ac303628j", "23388050"]}, {"Citation": "Ferrari M. Frontiers in cancer nanomedicine: Directing mass transport through biological barriers. Trends Biotechnol. 2010;28:181\u2013188. doi: 10.1016/j.tibtech.2009.12.007.", "ArticleIdList": ["10.1016/j.tibtech.2009.12.007", "PMC2843761", "20079548"]}, {"Citation": "Zhang Y.S., Zhang Y.N., Zhang W. Cancer-on-a-chip systems at the frontier of nanomedicine. Drug Discov. Today. 2017;22:1392\u20131399. doi: 10.1016/j.drudis.2017.03.011.", "ArticleIdList": ["10.1016/j.drudis.2017.03.011", "PMC5610924", "28390929"]}, {"Citation": "Galler K., Brautigam K., Grosse C., Popp J., Neugebauer U. Making a big thing of a small cell\u2013recent advances in single cell analysis. Analyst. 2014;139:1237\u20131273. doi: 10.1039/C3AN01939J.", "ArticleIdList": ["10.1039/C3AN01939J", "24495980"]}, {"Citation": "Kayala M.A., Azencott C.A., Chen J.H., Baldi P. Learning to predict chemical reactions. J. Chem. Inf. Model. 2011;51:2209\u20132222. doi: 10.1021/ci200207y.", "ArticleIdList": ["10.1021/ci200207y", "PMC3193800", "21819139"]}, {"Citation": "Reynolds C.R., Muggleton S.H., Sternberg M.J. Incorporating virtual reactions into a logic-based ligand-based virtual screening method to discover new leads. Mol. Inform. 2015;34:615\u2013625. doi: 10.1002/minf.201400162.", "ArticleIdList": ["10.1002/minf.201400162", "PMC4641463", "26583052"]}, {"Citation": "Kowalik M., Gothard C.M., Drews A.M., Gothard N.A., Weckiewicz A., Fuller P.E., Grzybowski B.A., Bishop K.J. Parallel optimization of synthetic pathways within the network of organic chemistry. Angew. Chem. Int. Ed. Engl. 2012;51:7928\u20137932. doi: 10.1002/anie.201202209.", "ArticleIdList": ["10.1002/anie.201202209", "22807100"]}, {"Citation": "Szymkuc S., Gajewska E.P., Klucznik T., Molga K., Dittwald P., Startek M., Bajczyk M., Grzybowski B.A. Computer-assisted synthetic planning: The end of the beginning. Angew. Chem. Int. Ed. Engl. 2016;55:5904\u20135937. doi: 10.1002/anie.201506101.", "ArticleIdList": ["10.1002/anie.201506101", "27062365"]}, {"Citation": "Baker M. Europe bets on drug discovery. Nature. 2013;494:20. doi: 10.1038/494020a.", "ArticleIdList": ["10.1038/494020a", "23393658"]}, {"Citation": "Lopez-Rubio E., Elizondo D.A., Grootveld M., Jerez J.M., Luque-Baena R.M. Computational intelligence techniques in medicine. Comput. Math. Methods Med. 2015;2015:196976. doi: 10.1155/2015/196976.", "ArticleIdList": ["10.1155/2015/196976", "PMC4365332", "25834633"]}, {"Citation": "Montanez-Godinez N., Martinez-Olguin A.C., Deeb O., Garduno-Juarez R., Ramirez-Galicia G. QSAR/QSPR as an application of artificial neural networks. Methods Mol. Biol. 2015;1260:319\u2013333.", "ArticleIdList": ["25502390"]}, {"Citation": "Wesolowski M., Suchacz B. Artificial neural networks: Theoretical background and pharmaceutical applications: A review. J. AOAC Int. 2012;95:652\u2013668. doi: 10.5740/jaoacint.SGE_Wesolowski_ANN.", "ArticleIdList": ["10.5740/jaoacint.SGE_Wesolowski_ANN", "22816255"]}, {"Citation": "Baskin I.I., Winkler D., Tetko I.V. A renaissance of neural networks in drug discovery. Expert Opin. Drug Discov. 2016;11:785\u2013795. doi: 10.1080/17460441.2016.1201262.", "ArticleIdList": ["10.1080/17460441.2016.1201262", "27295548"]}, {"Citation": "Nikolsky Y., Nikolskaya T., Bugrim A. Biological networks and analysis of experimental data in drug discovery. Drug Discov. Today. 2005;10:653\u2013662. doi: 10.1016/S1359-6446(05)03420-3.", "ArticleIdList": ["10.1016/S1359-6446(05)03420-3", "15894230"]}, {"Citation": "LeCun Y., Bengio Y., Hinton G. Deep learning. Nature. 2015;521:436\u2013444. doi: 10.1038/nature14539.", "ArticleIdList": ["10.1038/nature14539", "26017442"]}, {"Citation": "Lipinski C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods. 2000;44:235\u2013249. doi: 10.1016/S1056-8719(00)00107-6.", "ArticleIdList": ["10.1016/S1056-8719(00)00107-6", "11274893"]}, {"Citation": "Congreve M., Carr R., Murray C., Jhoti H. A \u2018rule of three\u2019 for fragment-based lead discovery? Drug Discov. Today. 2003;8:876\u2013877. doi: 10.1016/S1359-6446(03)02831-9.", "ArticleIdList": ["10.1016/S1359-6446(03)02831-9", "14554012"]}, {"Citation": "Van Molle I., Thomann A., Buckley D.L., So E.C., Lang S., Crews C.M., Ciulli A. Dissecting fragment-based lead discovery at the von Hippel-Lindau protein: Hypoxia inducible factor 1alpha protein-protein interface. Chem. Biol. 2012;19:1300\u20131312. doi: 10.1016/j.chembiol.2012.08.015.", "ArticleIdList": ["10.1016/j.chembiol.2012.08.015", "PMC3551621", "23102223"]}, {"Citation": "Zuegg J., Cooper M.A. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening. Curr. Top. Med. Chem. 2012;12:1500\u20131513. doi: 10.2174/156802612802652466.", "ArticleIdList": ["10.2174/156802612802652466", "22827520"]}, {"Citation": "Ntie-Kang F., Lifongo L.L., Judson P.N., Sippl W., Efange S.M. How \u201cdrug-like\u201d are naturally occurring anti-cancer compounds? J. Mol. Model. 2014;20:2069. doi: 10.1007/s00894-014-2069-z.", "ArticleIdList": ["10.1007/s00894-014-2069-z", "24452907"]}, {"Citation": "Grabowski K., Baringhaus K.H., Schneider G. Scaffold diversity of natural products: Inspiration for combinatorial library design. Nat. Prod. Rep. 2008;25:892\u2013904. doi: 10.1039/b715668p.", "ArticleIdList": ["10.1039/b715668p", "18820757"]}, {"Citation": "Elumalai N., Berg A., Natarajan K., Scharow A., Berg T. Nanomolar inhibitors of the transcription factor STAT5b with high selectivity over STAT5a. Angew. Chem. Int. Ed. Engl. 2015;54:4758\u20134763. doi: 10.1002/anie.201410672.", "ArticleIdList": ["10.1002/anie.201410672", "PMC4471549", "25702814"]}, {"Citation": "Bon R.S., Waldmann H. Bioactivity-guided navigation of chemical space. Acc. Chem. Res. 2010;43:1103\u20131114. doi: 10.1021/ar100014h.", "ArticleIdList": ["10.1021/ar100014h", "20481515"]}, {"Citation": "Renner S., van Otterlo W.A., Dominguez Seoane M., Mocklinghoff S., Hofmann B., Wetzel S., Schuffenhauer A., Ertl P., Oprea T.I., Steinhilber D., et al. Bioactivity-guided mapping and navigation of chemical space. Nat. Chem. Biol. 2009;5:585\u2013592. doi: 10.1038/nchembio.188.", "ArticleIdList": ["10.1038/nchembio.188", "19561619"]}, {"Citation": "Wetzel S., Klein K., Renner S., Rauh D., Oprea T.I., Mutzel P., Waldmann H. Interactive exploration of chemical space with scaffold hunter. Nat. Chem. Biol. 2009;5:581\u2013583. doi: 10.1038/nchembio.187.", "ArticleIdList": ["10.1038/nchembio.187", "19561620"]}, {"Citation": "Rodrigues T., Reker D., Schneider P., Schneider G. Counting on natural products for drug design. Nat. Chem. 2016;8:531\u2013541. doi: 10.1038/nchem.2479.", "ArticleIdList": ["10.1038/nchem.2479", "27219696"]}, {"Citation": "Lagunin A., Stepanchikova A., Filimonov D., Poroikov V. Pass: Prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16:747\u2013748. doi: 10.1093/bioinformatics/16.8.747.", "ArticleIdList": ["10.1093/bioinformatics/16.8.747", "11099264"]}, {"Citation": "Stepanchikova A.V., Lagunin A.A., Filimonov D.A., Poroikov V.V. Prediction of biological activity spectra for substances: Evaluation on the diverse sets of drug-like structures. Curr. Med. Chem. 2003;10:225\u2013233. doi: 10.2174/0929867033368510.", "ArticleIdList": ["10.2174/0929867033368510", "12570709"]}, {"Citation": "Reker D., Rodrigues T., Schneider P., Schneider G. Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus. Proc. Natl. Acad. Sci. USA. 2014;111:4067\u20134072. doi: 10.1073/pnas.1320001111.", "ArticleIdList": ["10.1073/pnas.1320001111", "PMC3964060", "24591595"]}, {"Citation": "Schneider G., Reker D., Rodrigues T., Schneider P. Coping with polypharmacology by computational medicinal chemistry. Chimia. 2014;68:648\u2013653. doi: 10.2533/chimia.2014.648.", "ArticleIdList": ["10.2533/chimia.2014.648", "25437786"]}, {"Citation": "Sliwoski G., Kothiwale S., Meiler J., Lowe E.W. Computational methods in drug discovery. Pharmacol. Rev. 2014;66:334\u2013395. doi: 10.1124/pr.112.007336.", "ArticleIdList": ["10.1124/pr.112.007336", "PMC3880464", "24381236"]}, {"Citation": "DiMasi J.A., Feldman L., Seckler A., Wilson A. Trends in risks associated with new drug development: Success rates for investigational drugs. Clin. Pharmacol. Ther. 2010;87:272\u2013277. doi: 10.1038/clpt.2009.295.", "ArticleIdList": ["10.1038/clpt.2009.295", "20130567"]}, {"Citation": "DiMasi J.A., Reichert J.M., Feldman L., Malins A. Clinical approval success rates for investigational cancer drugs. Clin. Pharmacol. Ther. 2013;94:329\u2013335. doi: 10.1038/clpt.2013.117.", "ArticleIdList": ["10.1038/clpt.2013.117", "23739536"]}, {"Citation": "Hay M., Thomas D.W., Craighead J.L., Economides C., Rosenthal J. Clinical development success rates for investigational drugs. Nat. Biotechnol. 2014;32:40\u201351. doi: 10.1038/nbt.2786.", "ArticleIdList": ["10.1038/nbt.2786", "24406927"]}, {"Citation": "Loong H.H., Siu L.L. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Meeting. American Society of Clinical Oncology; Alexandria, VA, USA: 2013. Selecting the best drugs for phase I clinical development and beyond; pp. 469\u2013473.", "ArticleIdList": ["23714572"]}, {"Citation": "Chavan S., Nicholls I.A., Karlsson B.C., Rosengren A.M., Ballabio D., Consonni V., Todeschini R. Towards global qsar model building for acute toxicity: Munro database case study. Int. J. Mol. Sci. 2014;15:18162\u201318174. doi: 10.3390/ijms151018162.", "ArticleIdList": ["10.3390/ijms151018162", "PMC4227209", "25302621"]}, {"Citation": "Cherkasov A., Muratov E.N., Fourches D., Varnek A., Baskin I.I., Cronin M., Dearden J., Gramatica P., Martin Y.C., Todeschini R., et al. Qsar modeling: Where have you been? Where are you going to? J. Med. Chem. 2014;57:4977\u20135010. doi: 10.1021/jm4004285.", "ArticleIdList": ["10.1021/jm4004285", "PMC4074254", "24351051"]}, {"Citation": "Devillers J. Methods for building QSARs. Methods Mol. Biol. 2013;930:3\u201327.", "ArticleIdList": ["23086835"]}, {"Citation": "Sullivan K.M., Manuppello J.R., Willett C.E. Building on a solid foundation: SAR and QSAR as a fundamental strategy to reduce animal testing. SAR QSAR Environ. Res. 2014;25:357\u2013365. doi: 10.1080/1062936X.2014.907203.", "ArticleIdList": ["10.1080/1062936X.2014.907203", "24773450"]}, {"Citation": "Kirchmair J., Goller A.H., Lang D., Kunze J., Testa B., Wilson I.D., Glen R.C., Schneider G. Predicting drug metabolism: Experiment and/or computation? Nat. Rev. Drug Discov. 2015;14:387\u2013404. doi: 10.1038/nrd4581.", "ArticleIdList": ["10.1038/nrd4581", "25907346"]}, {"Citation": "Mukherjee G., Lal Gupta P., Jayaram B. Predicting the binding modes and sites of metabolism of xenobiotics. Mol. BioSyst. 2015;11:1914\u20131924. doi: 10.1039/C5MB00118H.", "ArticleIdList": ["10.1039/C5MB00118H", "25913019"]}, {"Citation": "Xiao X., Min J.L., Lin W.Z., Liu Z., Cheng X., Chou K.C. Idrug-target: Predicting the interactions between drug compounds and target proteins in cellular networking via benchmark dataset optimization approach. J. Biomol. Struct. Dyn. 2015;33:2221\u20132233. doi: 10.1080/07391102.2014.998710.", "ArticleIdList": ["10.1080/07391102.2014.998710", "25513722"]}, {"Citation": "Zhang W., Liu F., Luo L., Zhang J. Predicting drug side effects by multi-label learning and ensemble learning. BMC Bioinform. 2015;16:365. doi: 10.1186/s12859-015-0774-y.", "ArticleIdList": ["10.1186/s12859-015-0774-y", "PMC4634905", "26537615"]}, {"Citation": "Bastian L., Hof J., Pfau M., Fichtner I., Eckert C., Henze G., Prada J., von Stackelberg A., Seeger K., Shalapour S. Synergistic activity of bortezomib and hdaci in preclinical models of b-cell precursor acute lymphoblastic leukemia via modulation of p53, pi3k/akt, and nf-kappab. Clin. Cancer Res. 2013;19:1445\u20131457. doi: 10.1158/1078-0432.CCR-12-1511.", "ArticleIdList": ["10.1158/1078-0432.CCR-12-1511", "23357978"]}, {"Citation": "Stanciu-Herrera C., Morgan C., Herrera L. Anti-cd19 and anti-cd22 monoclonal antibodies increase the effectiveness of chemotherapy in pre-b acute lymphoblastic leukemia cell lines. Leukemia Res. 2008;32:625\u2013632. doi: 10.1016/j.leukres.2007.07.002.", "ArticleIdList": ["10.1016/j.leukres.2007.07.002", "PMC2276361", "17706771"]}, {"Citation": "Dzobo K., Senthebane D.A., Rowe A., Thomford N.E., Mwapagha L.M., Al-Awwad N., Dandara C., Parker M.I. Cancer stem cell hypothesis for therapeutic innovation in clinical oncology? Taking the root out, not chopping the leaf. Omics. 2016;20:681\u2013691. doi: 10.1089/omi.2016.0152.", "ArticleIdList": ["10.1089/omi.2016.0152", "27930094"]}, {"Citation": "Dzobo K., Senthebane D.A., Thomford N.E., Rowe A., Dandara C., Parker M.I. Not everyone fits the mold: Intratumor and intertumor heterogeneity and innovative cancer drug design and development. Omics. 2018;22:17\u201334. doi: 10.1089/omi.2017.0174.", "ArticleIdList": ["10.1089/omi.2017.0174", "29356626"]}, {"Citation": "Baselga J., Cortes J., Kim S.B., Im S.A., Hegg R., Im Y.H., Roman L., Pedrini J.L., Pienkowski T., Knott A., et al. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N. Engl. J. Med. 2012;366:109\u2013119. doi: 10.1056/NEJMoa1113216.", "ArticleIdList": ["10.1056/NEJMoa1113216", "PMC5705202", "22149875"]}, {"Citation": "Kawajiri H., Takashima T., Kashiwagi S., Noda S., Onoda N., Hirakawa K. Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer. Expert Rev. Anticancer Ther. 2015;15:17\u201326. doi: 10.1586/14737140.2015.992418.", "ArticleIdList": ["10.1586/14737140.2015.992418", "25494663"]}, {"Citation": "Swain S.M., Baselga J., Kim S.B., Ro J., Semiglazov V., Campone M., Ciruelos E., Ferrero J.M., Schneeweiss A., Heeson S., et al. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N. Engl. J. Med. 2015;372:724\u2013734. doi: 10.1056/NEJMoa1413513.", "ArticleIdList": ["10.1056/NEJMoa1413513", "PMC5584549", "25693012"]}, {"Citation": "Swain S.M., Baselga J., Miles D., Im Y.H., Quah C., Lee L.F., Cortes J. Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: Results from the randomized phase iii study cleopatra. Ann. Oncol. 2014;25:1116\u20131121. doi: 10.1093/annonc/mdu133.", "ArticleIdList": ["10.1093/annonc/mdu133", "PMC4037862", "24685829"]}, {"Citation": "Swain S.M., Kim S.B., Cortes J., Ro J., Semiglazov V., Campone M., Ciruelos E., Ferrero J.M., Schneeweiss A., Knott A., et al. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (cleopatra study): Overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol. 2013;14:461\u2013471. doi: 10.1016/S1470-2045(13)70130-X.", "ArticleIdList": ["10.1016/S1470-2045(13)70130-X", "PMC4076842", "23602601"]}, {"Citation": "National Academy of Sciences (US) Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. National Academies Press (US), National Academy of Sciences; Washington, DC, USA: 2011. The national academies collection: Reports funded by national institutes of health.", "ArticleIdList": ["22536618"]}, {"Citation": "Debouck C. Integrating genomics across drug discovery and development. Toxicol. Lett. 2009;186:9\u201312. doi: 10.1016/j.toxlet.2008.09.011.", "ArticleIdList": ["10.1016/j.toxlet.2008.09.011", "18930125"]}, {"Citation": "Debouck C., Metcalf B. The impact of genomics on drug discovery. Ann. Rev. Pharmacol. Toxicol. 2000;40:193\u2013207. doi: 10.1146/annurev.pharmtox.40.1.193.", "ArticleIdList": ["10.1146/annurev.pharmtox.40.1.193", "10836133"]}]}], "History": [{"Year": "2018", "Month": "4", "Day": "27"}, {"Year": "2018", "Month": "5", "Day": "16"}, {"Year": "2018", "Month": "5", "Day": "18"}, {"Year": "2018", "Month": "5", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["29799486", "PMC6032166", "10.3390/ijms19061578", "ijms19061578"]}}]}